Referencer – Kapitel 6

^[624] Autoimmune Diseases: How Does Cannabis Help? http://herb.co/2016/10/04/autoimmune-diseases/

^[625] Can Arthritis Pain & Inflammation Be Treated With Cannabis? http://herb.co/2016/08/06/arthritis-pain-inflammation/

^[626] Cannabis vs. Lupus. http://herb.co/2016/05/15/cannabis-vs-lupus/

^[627] Celiac Disease And Cannabis: Is Help At Hand? http://herb.co/2016/02/12/celiac-disease-and-cannabis/

^[628] Skin Deep #2: How To Treat Psoriasis With Cannabis. http://herb.co/2016/05/28/skin-deep-psoriasis/

^[629] Marijuana and Diabetes – An In-depth Look. http://herb.co/2015/11/17/marijuana-and-diabetes/

^[630] Multiple Sclerosis: Here’s Why Cannabis Is So Effective Against MS. http://herb.co/2016/07/28/marijuana-and-ms/

^[631] The Endocannabinoid System For Dummies (We’ve Made It Easy For You). http://herb.co/2016/07/28/endocannabinoid-system-dummies/

^[632] Why Are Cannabinoid Receptors Important? http://herb.co/2016/02/22/why-are-cannabinoid-receptors-so-important/

^[633] PÁL PACHER, SÁNDOR BÁTKAI, GEORGE KUNOS: The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol Rev. 2006 Sep; 58(3): 389–462. doi:  10.1124/pr.58.3.2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/

^[634] Cabral GA¹, Staab A. Effects on the immune system. Handb Exp Pharmacol. 2005;(168):385-423. https://www.ncbi.nlm.nih.gov/pubmed/16596782

^[635] Cannabis, cannabinoids and cancer – the evidence so far. http://scienceblog.cancerresearchuk.org/2012/07/25/cannabis-cannabinoids-and-cancer-the-evidence-so-far/

^[636] Cancer Institute Finally Admits Marijuana Kills Cancer. http://herb.co/2015/10/02/cancer-institute-finally-admits-marijuana-kills-cancer/

^[637] Appendino G¹, Gibbons S, Giana A. et al.: Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod. 2008 Aug;71(8):1427-30. doi: 10.1021/np8002673. Epub 2008 Aug 6. https://www.ncbi.nlm.nih.gov/pubmed/18681481

Giovanni Appendino, Simon Gibbons, Anna Giana et al.: Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study. J. Nat. Prod., 2008, 71 (8), pp 1427–1430. http://pubs.acs.org/doi/full/10.1021/np8002673

Turner CE, Elsohly MA: Biological activity of cannabichromene, its homologs and isomers. J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):283S-291S. https://www.ncbi.nlm.nih.gov/pubmed/7298870

A New MRSA Defense. https://www.technologyreview.com/s/410815/a-new-mrsa-defense/

Is Marijuana The Next Big Antibiotic? https://herb.co/2016/01/27/marijuana-next-big-antibiotic/

^[638] How cannabis suppresses immune functions: Cannabis compounds found to trigger unique immune cells which promote cancer growth. https://www.sciencedaily.com/releases/2010/11/101124214728.htm

Venkatesh L. Hegde, Mitzi Nagarkatti and Prakash S. Nagarkatti. Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. European Journal of Immunology, 2010; 40 (12): 3358-3371 DOI: 10.1002/eji.201040667 https://www.ncbi.nlm.nih.gov/pubmed/21110319

^[639] Marijuana shows potential in treating autoimmune disease. https://www.sciencedaily.com/releases/2014/06/140602150914.htm

X. Yang, V. L. Hegde, R. Rao, J. Zhang, P. S. Nagarkatti, M. Nagarkatti. Histone modifications are associated with Delta(9)-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. Journal of Biological Chemistry, 2014; DOI: 10.1074/jbc.M113.545210

THC: Everything You Need To Know About Delta9-Tetrahydrocannabinol. http://herb.co/2016/07/24/what-is-thc/

^[640] Prakash Nagarkatti,^† Rupal Pandey,^* Sadiye Amcaoglu Rieder et al.: Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009 Oct; 1(7): 1333–1349.  doi:  10.4155/fmc.09.93https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/

Weiss L¹, Zeira M, Reich S, Slavin S. et al.: Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology. 2008 Jan;54(1):244-9. Epub 2007 Jul 17. https://www.ncbi.nlm.nih.gov/pubmed/17714746/

What Exactly Is CBD & Endocannabinoid Dysfunction? http://herb.co/2016/09/30/endocannabinoid-dysfunction/

^[641] CBD: Everything You Need To Know About Cannabidiol. http://herb.co/2016/07/26/everything-you-need-to-know-about-cbd/

^[642] Crippa et al. (2010). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of Psychopharmacology, 25(1), 21-30. doi: 10.1177/0269881110379283. https://www.ncbi.nlm.nih.gov/pubmed/20829306

^[643] Shoval et al. (2016). Prohedonic effect of cannabidiol in a rat model of depression. Neuropsychobiology, 73(2), 123-129. doi: 10.1159/000443890. https://www.ncbi.nlm.nih.gov/pubmed/27010632

^[644] Ware et al. (2002). Cannabis for chronic pain: case series and implications for clinicians. Pain Research Management, 7(2), 95-99. https://www.ncbi.nlm.nih.gov/pubmed/12185373

^[645] Tracey – Multiple Sclerosis and Medical Marijuana. https://www.youtube.com/watch?v=PGpEixXNx7A

^[646] Scleroseramt om medicinsk cannabis: – Det er en befrielse

https://www.tv2fyn.dk/artikel/scleroseramt-om-medicinsk-cannabis-det-er-en-befrielse

^[647] Skleroseramt: Vil gerne bruge cannabis legalt

https://www.tvmidtvest.dk/artikel/skleroseramt-vil-gerne-bruge-cannebis-legalt

^[648] Cannabis-Based Medicine For Patients Living With Multiple Sclerosis http://www.medicaljane.com/2014/06/08/cannabis-classroom-cannabis-based-medicine-for-patients-living-with-multiple-sclerosis/

Shaheen E Lakhan, Marie Rowland: Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. Global Neuroscience Initiative Foundation, Los Angeles, CA, USA. http://www.greenmedinfo.com/article/whole-plant-cannabis-provides-subjective-symptom-relief-multiple-sclerosis

Nagarkatti et al. (2009). Cannabinoids as novel anti-inflammatory drugs. Future Medical Chemistry, 1(7), 1333-1349. doi:10.4155/fmc.09.93.

^[649] Croxford et al. (2008). Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. Journal of Neuroimmunology, 193, 120– 129. https://www.ncbi.nlm.nih.gov/pubmed/18037503

^[650] Marijuana and muscle spasms.https://herb.co/marijuana/news/marijuana-and-muscle-spasms

Prakash Nagarkatti,^† Rupal Pandey,^* Sadiye Amcaoglu Rieder et al.: Cannabinoids as novel anti-inflammatory drugs.

Future Med Chem. 2009 Oct; 1(7): 1333–1349. doi:  10.4155/fmc.09.93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/

^[651] Forsøgsordning med medicinsk cannabis (Multipel (dissemineret) sklerose). https://pro.medicin.dk/Laegemiddelgrupper/Grupper/318748#a000

^[652] Svagere virkende præparater (1. linje-behandlinger) mod attakvis multipel sklerose. https://pro.medicin.dk/Laegemiddelgrupper/Grupper/318726#a000

^[653] Progressive multifocal leukoencephalopathy. https://en.wikipedia.org/wiki/Progressive_multifocal_leukoencephalopathy

Natalizumab-behandling af MS. http://neuro.dk/wordpress/nnbv/natalizumab-behandling-af-ms/

^[654] Gilenya lige så sikkert og effektivt på lang som på kort sigt. https://mstidsskrift.dk/behandling/medicin/120-gilenya-lige-sa-sikkert-og-effektivt-pa-lang-som-pa-kort-sigt.html

^[655] 5 Diseases Cannabis Treats Better Than Prescription Drugs. http://herb.co/2016/09/09/prescription-drugs/

^[656] Medical Marijuana and Chronic Pain. https://www.marijuanadoctors.com/conditions/chronic-pain/

^[657] Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana. https://wakeup-world.com/2016/10/14/still-believe-nature-got-it-wrong-top-10-health-benefits-of-marijuana/

^[658] Pertwee, R.G. (2002). Cannabinoids and multiple sclerosis. Pharmacology Therapies, 2002. 95, 165–174. https://www.ncbi.nlm.nih.gov/pubmed/12182963

Arevalo-Martin et al. (2008). CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. British Journal of Pharmacology, 153, 216–225. https://www.ncbi.nlm.nih.gov/pubmed/17891163

^[659] This Scientist Thinks Cannabis Could Be A Wonder Drug For Treating MS http://www.huffingtonpost.com/entry/cannabis-medical-marijuana-multiple-sclerosis-ms_us_587f95f5e4b0c147f0bc27b4?utm_hp_ref=medical-marijuana&utm_content=buffer4008c&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

^[660] Cannabis Saved My Life — Multiple Sclerosis. http://reset.me/story/cannabis-saved-my-life-multiple-sclerosis/

^[661] HE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE

Health and Medicine Division. Board on Population Health and Public Health Practice 

Committee of the Health Effects of Marijuana: An Evidence Review and Research Agenda. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=24625&_ga=1.172863584.235057739.1484262362

^[662] Marijuana and muscle spasms.https://herb.co/marijuana/news/marijuana-and-muscle-spasms

^[663] A Feliú, M Moreno-Martet, M Mecha et al.: A Sativex^®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. BJP Volume 172, Issue 14 July 2015 Pages 3579–3595.http://onlinelibrary.wiley.com/doi/10.1111/bph.13159/full

4 sygdomme vi kan behandle med cannabis. http://illvid.dk/medicin/laegemidler/4-sygdomme-vi-kan-behandle-med-cannabis

^[664] John Zajicek, Susan Ball, David Wright et al.: Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.  Lancet Neurology Volume 12, No. 9, p 857–865, September 2013. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70159-5/abstract

^[665] Kimia Honarmand, Mary C. Tierney, Paul O’Connor et al.: Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology March 29, 2011; 76 (13). http://n.neurology.org/content/76/13/1153?sid=f9a2b534-8d6f-4ad2-b2ac-22d714f227ce

^[666] Bennis Pavisian, Bradley J. MacIntosh, Greg Szilagyi et al.: Effects of cannabis on cognition in patients with MS. Neurology April 30, 2014. http://n.neurology.org/content/early/2014/04/30/WNL.0000000000000446.short

Medical Marijuana (Cannabis). https://www.nationalmssociety.org/Treating-MS/Complementary-Alternative-Medicines/Marijuana

Multiple Sclerosis (MS). Oversigt over studier. https://www.projectcbd.org/multiple-sclerosis-ms

^[667] Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology. 2004;62:2098–100. https://www.ncbi.nlm.nih.gov/pubmed/15184623

Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci. 2003;30:201–5. https://www.ncbi.nlm.nih.gov/pubmed/12945941

^[668] Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, et al. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012;184:1143–50. https://www.ncbi.nlm.nih.gov/pubmed/22586334

Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O’Connor P, Feinstein A. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study. Neurology. 2014;82:1879–87. https://www.ncbi.nlm.nih.gov/pubmed/24789863

Honarmand K, Tierney MC, O’Connor P, Feinstein A. Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology. 2011;76:1153–60. https://www.ncbi.nlm.nih.gov/pubmed/21444900

^[669] Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41:685–91. https://indiana.pure.elsevier.com/en/publications/cognitive-dysfunction-in-multiple-sclerosis-i-frequency-patterns-

^[670] Medical Marijuana (Cannabis). https://www.nationalmssociety.org/Treating-MS/Complementary-Alternative-Medicines/Marijuana

^[671] Giacoppo S¹, Pollastro F², Grassi G. et al.: Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia. 2017 Jan;116:77-84. doi: 10.1016/j.fitote.2016.11.010. Epub 2016 Nov 25. https://www.ncbi.nlm.nih.gov/pubmed/27890794

^[672] Cannabis vs. Lupus. https://herb.co/marijuana/news/cannabis-vs-lupus

^[673] Wen Jiang,1,2 Yun Zhang,1 Lan Xiao et al.: Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. : J Clin Invest. 2005;115(11):3104-3116.https://doi.org/10.1172/JCI25509. https://www.jci.org/articles/view/25509/pdf

^[674] Hampson AJ¹, Grimaldi M, Lolic M, Wink D. et al.: Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci. 2000;899:274-82. https://www.ncbi.nlm.nih.gov/pubmed/10863546

^[675] Kozela E¹, Juknat A, Kaushansky N.et al.: Cannabinoids decrease the th17 inflammatory autoimmune phenotype. J Neuroimmune Pharmacol. 2013 Dec;8(5):1265-76. doi: 10.1007/s11481-013-9493-1. Epub 2013 Jul 28. https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1007%2Fs11481-013-9493-1

^[676] Benefits Of Cannabis For Multiple Sclerosis. https://zenpype.com/benefits-of-cannabis-for-multiple-sclerosis/

Amazing Uses of CBD. https://zenpype.com/amazing-uses-of-cbd/

^[677] Henadzi Basinski, Henrik Boye Jensen, Egon Stenager. There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis. Ugeskr Læger 2014;176:V09130552. http://ugeskriftet.dk/videnskab/der-er-evidens-brug-af-cannabinoider-til-symptomatisk-behandling-af-multipel-sklerose

^[678] Ewa Kozela, Nirit Lev, Nathali Kaushansky et al.: Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. British Journal of Pharmacology (2011) 163 1507–1519 1507. https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1476-5381.2011.01379.x

Study: Marijuana Compounds Protect Nervous System In MS. http://www.leafscience.com/2013/10/17/study-marijuana-compounds-protect-nervous-system-ms/

^[679] Cannabinoids Show Promise In Slowing MS, But ‘High’ Raises Concern. https://www.leafscience.com/2013/10/07/cannabinoids-show-promise-slowing-ms-high-raises-concern/

Smoking Medical Marijuana Can Decrease Pain From Multiple Sclerosis (MS). https://www.medicaljane.com/2013/01/03/multiple-sclerosis-and-marijuana/

^[680] A Feliú, M Moreno-Martet, M Mecha et al.: A Sativex^®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. BJP Volume 172, Issue 14 July 2015  Pages 3579–3595.

http://onlinelibrary.wiley.com/doi/10.1111/bph.13159/full

4 sygdomme vi kan behandle med cannabis. http://illvid.dk/medicin/laegemidler/4-sygdomme-vi-kan-behandle-med-cannabis

^[681] Study: CBD-Based Topicals May Aid In Alcoholism Treatment. https://www.medicaljane.com/2013/09/13/cannabis-topicals-study-cannabis-topicals-may-aid-in-alcoholism-treatment-aid-in-alcoholism-treatment/

Study: Topical CBD Treatment May Reduce Central Nervous System Inflammation https://www.medicaljane.com/2015/11/25/study-topical-cbd-treatment-may-reduce-central-nervous-system-inflammation/

^[682] Giacoppo S¹, Galuppo M¹, Pollastro et al.: A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Daru. 2015 Oct 21;23:48. doi: 10.1186/s40199-015-0131-8. https://www.ncbi.nlm.nih.gov/pubmed/26489494

^[683] Medical Marijuana and Multiple Sclerosis (MS). https://www.marijuanadoctors.com/conditions/multiple-sclerosis-ms/

^[684] Pain. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Pain

Vaporizing Cannabis: Possible Treatment For Neuropathic Pain Symptoms. https://www.medicaljane.com/2013/08/16/vaporizing-cannabis-is-an-effective-treatment-for-neuropathic-pain/

^[685] Using Cannabis to Control MS-Related Pain. https://www.marijuanadoctors.com/resources/ailment-resources/using-cannabis-control-ms-related-pain/

^[686] Vaporizing Cannabis: Possible Treatment For Neuropathic Pain Symptoms. https://www.medicaljane.com/2013/08/16/vaporizing-cannabis-is-an-effective-treatment-for-neuropathic-pain/

^[687] Wilsey B¹, Marcotte T, Tsodikov A. et al.: A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain. 2008 Jun;9(6):506-21. doi: 10.1016/j.jpain.2007.12.010. Epub 2008 Apr 10. https://www.ncbi.nlm.nih.gov/pubmed/18403272

Mark A. Ware, Tongtong Wang,  Stan Shapiro et al.: Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010 Oct 5; 182(14): E694–E701. doi:  10.1503/cmaj.091414.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/

The Best Strains of Marijuana For Pain Relief. https://herb.co/marijuana/news/marijuana-for-pain

^[688] Gertsch et al. Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences, 2008; 105 (26): 9099 DOI: 10.1073/pnas.0803601105

Why Cannabis Stems Inflammation. https://www.sciencedaily.com/releases/2008/07/080720222549.htm

^[689] Svendsen KB¹, Jensen TS, Bach FW.: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ. 2004 Jul 31;329(7460):253. Epub 2004 Jul 16. https://www.ncbi.nlm.nih.gov/pubmed/15258006

^[690] Kevin P. Hill: Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric ProblemsA Clinical Review. JAMA. 2015;313(24):2474-2483. doi:10.1001/jama.2015.6199. https://jamanetwork.com/journals/jama/article-abstract/2338266

^[691] Multiple Sclerosis: Here’s Why Cannabis Is So Effective Against MS. https://herb.co/marijuana/news/marijuana-and-ms

^[692] Barbara S. Koppel, John C.M. Brust, Terry Fife, et al.: Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014;82;1556-1563. http://www.medicinalgenomics.com/wp-content/uploads/2011/12/Efficacy-and-safety-of-medical-marijuana.pdf

Healing Herb? Marijuana Could Treat These 5 Conditions.https://www.livescience.com/55750-medical-marijuana-conditions-treat.html

^[693] Marijuana may ease multiple sclerosis symptoms. http://www.reuters.com/article/us-marijuana-sclerosis-idUSBRE84D0RS20120514

23 Fantastic Health Benefits Of Medical Marijuana. https://medicalmarijuana411.com/23-health-benefits-of-marijuana/

Smith PF. New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. Ther Clin Risk Manag. 2010;6:59-63. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/

Rog DJ, Nurmikko TJ, Young CA. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29(9):2068-2079. https://www.ncbi.nlm.nih.gov/pubmed/18035205

^[694] Jody Corey-Bloom, Tanya Wolfson, Anthony Gamst et al.: Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ May 14, 2012 First published May 14, 2012, doi: 10.1503/cmaj.110837. http://www.cmaj.ca/content/early/2012/05/14/cmaj.110837

^[695] Rog DJ¹, Nurmikko TJ, Friede T. et al.: Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005 Sep 27;65(6):812-9. https://www.ncbi.nlm.nih.gov/pubmed/16186518

^[696] Spasms and stiffness. https://www.mssociety.org.uk/about-ms/signs-and-symptoms/spasms-and-stiffness

^[697] Barbara S. Koppel, John C.M. Brust, Terry Fife et al.: Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders. Neurology. 2014 Apr 29; 82(17): 1556–1563.  doi: 10.1212/WNL.0000000000000363

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011465/

Wade DT¹, Collin C, Stott C, Duncombe P. et al.: Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler. 2010 Jun;16(6):707-14. doi: 10.1177/1352458510367462. https://www.ncbi.nlm.nih.gov/pubmed/20558502

^[698] Marijuana and Cancer. http://www.cancer.org/treatment/treatmentsandsideeffects/physicalsideeffects/chemotherapyeffects/marijuana-and-cancer

Jody Corey-Bloom, Tanya Wolfson, Anthony Gamst et al.: Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012 Jul 10; 184(10): 1143–1150. doi:  10.1503/cmaj.110837

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394820/

^[699] Medical Marijuana (Cannabis).  http://www.nationalmssociety.org/Treating-MS/Complementary-Alternative-Medicines/Marijuana

^[700] Anita L Slade et al.: Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. Journal of neurology, neurosurgery, and psychiatry · July 2012. https://www.researchgate.net/profile/Anita_Slade/publication/229082908_MUltiple_Sclerosis_and_Extract_of_Cannabis_results_of_the_MUSEC_trial/links/54e759610cf2b199060bc9ec.pdf

Anna Maria Malfitano, Maria Chiara Proto, Maurizio Bifulco: Cannabinoids in the management of spasticity associated with multiple sclerosis. Neuropsychiatr Dis Treat. 2008 Oct; 4(5): 847–853. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626929/

Sativex Shown To Treat Spasticity In Multiple Sclerosis (MS). https://www.medicaljane.com/2014/02/17/german-study-cannabinoids-may-effectively-treat-multiple-sclerosis-ms/

^[701] Pandyan AD, Gregoric M, Barnes MP, Wood D, van Wijck F, Burridge J, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27:2–6. https://www.tandfonline.com/doi/abs/10.1080/09638280400014576

Katherine A Belendiuk, Lisa L Baldini, Marcel O Bonn-Miller: Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice December 2015, 10:10. https://link.springer.com/article/10.1186/s13722-015-0032-7

^[702] Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess. 2003;7(40):1–111. https://www.ncbi.nlm.nih.gov/pubmed/14636486

^[703] Novotna A, Mares J, Ratcliffe S, Novakova I et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols*(Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol. 2011;18:1122–31. https://www.ncbi.nlm.nih.gov/pubmed/21362108

Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler. 2004;10:434–41. https://www.ncbi.nlm.nih.gov/pubmed/15327042

Collin C, Davies P, Mutiboko IK, Ratcliffe S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol. 2007;14:290–6. https://www.ncbi.nlm.nih.gov/pubmed/17355549

Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 2003;17:21–9. https://www.ncbi.nlm.nih.gov/pubmed/12617376

Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, et al. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry. 2005;76:1664–9. https://www.ncbi.nlm.nih.gov/pubmed/16291891

Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet. 2003;362:1517–26. https://www.ncbi.nlm.nih.gov/pubmed/14615106

Pooyania S, Ethans K, Szturm T, Casey A, Perry D. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch Phys Med Rehabil. 2010;91:703–7. https://www.ncbi.nlm.nih.gov/pubmed/20434606

^[704] Wade DT, Makela PM, House H, Bateman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler. 2006;12:639–45. https://www.ncbi.nlm.nih.gov/pubmed/17086911

Serpell MG, Notcutt W, Collin C. Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. J Neurol. 2013;260:285–95. https://www.ncbi.nlm.nih.gov/pubmed/22878432

Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R. A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex®(nabiximols). Mult Scler. 2012;18:219–28. https://www.ncbi.nlm.nih.gov/pubmed/21878454

^[705] Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols*(Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol. 2011;18:1122–31. https://www.ncbi.nlm.nih.gov/pubmed/21362108

Flachenecker P, Henze T, Zettl UK. Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice—results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol. 2014;71:271–9. https://www.ncbi.nlm.nih.gov/pubmed/24525548

^[706] Zajicek JP¹, Hobart JC, Slade A. et al.: Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1125-32. doi: 10.1136/jnnp-2012-302468. Epub 2012 Jul 12. https://www.ncbi.nlm.nih.gov/pubmed/22791906

Medical Marijuana (Cannabis). https://www.nationalmssociety.org/Treating-MS/Complementary-Alternative-Medicines/Marijuana

Multiple Sclerosis (MS). Oversigt over studier. https://www.projectcbd.org/multiple-sclerosis-ms

^[707] Whole-Plant Cannabis Concentrates Could Offer Broad Spectrum Benefits. https://www.medicaljane.com/2014/01/23/whole-plant-cannabis-concentrates-could-offer-broad-spectrum-benefits/

^[708] Vermersch P¹, Trojano M.: Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice. Eur Neurol. 2016;76(5-6):216-226. Epub 2016 Oct 13 https://www.ncbi.nlm.nih.gov/pubmed/27732980

What is Sativex (Nabiximols)? https://www.leafscience.com/2017/11/02/what-is-sativex-nabiximols/

What Are The Medical Benefits of CBD?https://www.leafscience.com/2017/12/06/medical-benefits-cbd/

^[709] Medical Marijuana (Cannabis). https://www.nationalmssociety.org/Treating-MS/Complementary-Alternative-Medicines/Marijuana

Sativex Shown To Treat Spasticity In Multiple Sclerosis (MS) https://www.medicaljane.com/2014/02/17/german-study-cannabinoids-may-effectively-treat-multiple-sclerosis-ms/

Flachenecker P¹, Henze T, Zettl UK: Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice–results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol.2014;71(5-6):271-9. doi: 10.1159/000357427. Epub 2014 Feb 12. https://www.ncbi.nlm.nih.gov/pubmed/24525548

^[710] George Kunos, Pál Pacher: Cannabinoids cool the intestine. Nat Med. 2004 Jul; 10(7): 678–679.

doi:  10.1038/nm0704-678. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516444/

^[711] The Odd Science Behind Marijuana And Metabolism. https://herb.co/marijuana/news/odd-science-behind-marijuana-metabolism

Why Are Cannabinoid Receptors Important? https://herb.co/marijuana/news/why-are-cannabinoid-receptors-so-important

Multiple Sclerosis: Here’s Why Cannabis Is So Effective Against MS. https://herb.co/news/health/marijuana-and-ms/

5 Amazing Reasons Weed Makes Food Insanely Good. https://herb.co/marijuana/news/weed-food

^[712] Multiple Sclerosis and Vision Problems. https://www.webmd.com/multiple-sclerosis/multiple-sclerosis-vision-problems

^[713] Can Cannabis Treat Arthritis Pain and Inflammation? Here’s What Research is Saying. https://herb.co/marijuana/news/can-cannabis-treat-arthritis-pain-and-inflammation-heres-what-research-is-saying

^[714] Zajicek J¹, Fox P, Sanders H. et al.: Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet. 2003 Nov 8;362(9395):1517-26. https://www.ncbi.nlm.nih.gov/pubmed/14615106

PÁL PACHER, SÁNDOR BÁTKAI, GEORGE KUNOS: The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol Rev. 2006 Sep; 58(3): 389–462.  doi:  10.1124/pr.58.3.2.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/

^[715] EXPLORING RELIABILITY IN ACADEMIC ASSESSMENT. https://chfasoa.uni.edu/reliabilityandvalidity.htm

^[716] C Vaney, M Heinzel-Gutenbrunner, P Jobin et al.: Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Multiple Sclerosis 2004; 10: 417_/424. http://www.ukcia.org/research/EfficacySafetyTolerabilityInMSSpasticityTreatment.pdf

^[717] Collin C¹, Davies P, Mutiboko IK. Et al.: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol. 2007 Mar;14(3):290-6. https://www.ncbi.nlm.nih.gov/pubmed/17355549

^[718] Nøgletal for gigtsygdomme. 2. udgave, maj 2017. Gigtforeningen. https://www.gigtforeningen.dk/media/3434/gigtforeningens-noegletalspublikation-2017.pdf

^[719] 23 Fantastic Health Benefits Of Medical Marijuana. https://medicalmarijuana411.com/23-health-benefits-of-marijuana/

^[720] Medical Marijuana and Rheumatoid Arthritis

https://www.marijuanadoctors.com/content/ailments/view/109/rheumatoid-arthritis?utm_content=buffere88e9&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

^[721] Leddegigt. https://min.medicin.dk/Sygdomme/Sygdom/81

Behandling af leddegigt – medicin og andre behandlingsformer. https://www.gigtforeningen.dk/viden-om-gigt/diagnoser/leddegigt/behandling-af-leddegigt/

^[722] Kredsløbet kan tage skade af mild smertestillende medicin. https://videnskab.dk/krop-sundhed/kredsloebet-kan-tage-skade-af-mild-smertestillende-medicin

^[723] Schmidt M¹, Christiansen CF, Horváth-Puhó E. et al.: Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost. 2011 Jul;9(7):1326-33. doi: 10.1111/j.1538-7836.2011.04354.x. https://www.ncbi.nlm.nih.gov/pubmed/21592304

^[724] Smertestillende piller kan give blodpropper. https://videnskab.dk/krop-sundhed/smertestillende-piller-kan-give-blodpropper

^[725] Sondergaard KB¹, Weeke P², Wissenberg M. et al.: Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):100-107. doi: 10.1093/ehjcvp/pvw041. https://www.ncbi.nlm.nih.gov/pubmed/28025218

Harmless painkillers associated with increased risk of cardiac arrest. https://www.escardio.org/The-ESC/Press-Office/Press-releases/harmless-painkillers-associated-with-increased-risk-of-cardiac-arrest?hit=twitter#

^[726] https://herb.co/2016/08/06/arthritis-pain-inflammation/

^[727] Cannabis giver nyt håb til syge . http://www.bt.dk/danmark/cannabis-giver-nyt-haab-til-syge

^[728] Huan Gui, Xia Liu, Zhi-Wei Wang et al.: Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. Rheumatology, Volume 53, Issue 5, 1 May 2014, Pages 802–809, https://doi.org/10.1093/rheumatology/ket447. https://academic.oup.com/rheumatology/article/53/5/802/1798167

^[729] Why Are Cannabinoid Receptors Important? https://herb.co/2016/02/22/why-are-cannabinoid-receptors-so-important/

^[730] G. A. Cabral, L. Griffin-Thomas: Emerging Role of the CB₂ Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects. Expert Rev Mol Med. Author manuscript; available in PMC 2010 Jan 1.

Published in final edited form as: Expert Rev Mol Med. 2009 Jan 20; 11: e3.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/

^[731] Barbara Costa, Mariapia Colleoni, Silvia Conti et al.: Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn-Schmiedeberg’s Archives of Pharmacology March 2004, Volume 369, Issue 3, pp 294–299. https://link.springer.com/article/10.1007/s00210-004-0871-3#page-2

Malfait et al. (2000). The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Science (USA), 97, 9561–9566.https://www.ncbi.nlm.nih.gov/pubmed/10920191

Martin-Sanchez et al. (2009). Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine, 10(8), 1353-1368. doi: 10.1111/j.1526-4637.2009.00703.x. https://www.ncbi.nlm.nih.gov/pubmed/19732371

Parker et al. (2008). Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. Rheumatology International, 28, 631–635. https://www.ncbi.nlm.nih.gov/pubmed/18040689  

^[732] Marijuana shows potential in treating autoimmune disease. https://www.sciencedaily.com/releases/2014/06/140602150914.htm

X. Yang, V. L. Hegde, R. Rao, J. Zhang, P. S. Nagarkatti, M. Nagarkatti. Histone modifications are associated with Delta(9)-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. Journal of Biological Chemistry, 2014; DOI: 10.1074/jbc.M113.545210. https://www.ncbi.nlm.nih.gov/pubmed/24841204

^[733] Multiple Sclerosis: Here’s Why Cannabis Is So Effective Against MS. https://herb.co/2016/07/28/marijuana-and-ms/

^[734] Cannabis vs. Lupus. https://herb.co/2016/05/15/cannabis-vs-lupus/

^[735] Mechoulam on Cannabidiol. http://www.beyondthc.com/wp-content/uploads/2012/05/Mechoulam-on-CBD.pdf

^[736] Barbara Costa, Mariapia Colleoni, Silvia Conti et al.: Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn-Schmiedeberg’s Archives of Pharmacology March 2004, Volume 369, Issue 3, pp 294–299 . https://link.springer.com/article/10.1007/s00210-004-0871-3#page-2

^[737] Weed vs Opioids: Which Is Better For Pain? https://herb.co/2016/02/11/weed-vs-opioids-better-pain/

^[738] Mark A. Ware, Tongtong Wang, Stan Shapiro et al.: Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010 Oct 5; 182(14): E694–E701. doi:  10.1503/cmaj.091414.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/

^[739] Medical Marijuana For Rheumatoid Arthritis? http://www.huffingtonpost.com/2011/06/08/can-medical-marijuana-help-arthritis_n_873189.html

^[740] Mary E Lynch, Fiona Campbell: Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov; 72(5): 735–744. doi:  10.1111/j.1365-2125.2011.03970.x.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/

^[741] 60 Peer-Reviewed Studies on Medical Marijuana. https://medicalmarijuana.procon.org/view.resource.php?resourceID=000884

Blake DR¹, Robson P, Ho M. et al.: Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006 Jan;45(1):50-2. Epub 2005 Nov 9. https://www.ncbi.nlm.nih.gov/pubmed/16282192

^[742] Lal S¹, Prasad N, Ryan M et al.: Cannabis use amongst patients with inflammatory bowel disease. https://www.ncbi.nlm.nih.gov/pubmed/21795981

^[743] Klaus W. Lange,^1,3 Susanne Reichl,¹ Katharina M. Lange et al.: The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2010 Dec; 2(4): 241–255.  Published online 2010 Nov 30. doi:  10.1007/s12402-010-0045-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907/

^[744] Daley, David og Rasmus Højbjerg Jacobsen, Anne-Mette Lange, Anders Sørensen og Jeanette Walldorf: Private and Social Costs of ADHD: COST ANALYSIS. The Rockwool Foundation Research Unit, Study Paper No. 69, 2014.

 ADHD i tal – statistik over udbredelse, følger og medicin. https://adhd.dk/wp-content/uploads/sites/2/2014/11/ADHD-i-tal.pdf

^[745] Attention Deficit Disorder. https://medicalmarijuana411.com/attention-deficit-disorder/

ADHD: The Facts. https://add.org/adhd-facts/

Medical Marijuana and Attention Deficit Disorder (ADD). https://www.marijuanadoctors.com/conditions/attention-deficit-disorder-add/

Adult ADHD (Attention Deficit Hyperactive Disorder). https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/adult-adhd#

^[746] How Girls With ADHD Are Different. http://childmind.org/article/how-girls-with-adhd-are-different/

^[747] History of Benzedrine. https://en.wikipedia.org/wiki/History_of_Benzedrine

^[748] The History of ADHD: A Timeline. https://www.healthline.com/health/adhd/history#overview1

^[749] National klinisk retningslinje for udredning og behandling af ADHD hos børn og unge – med fokus på diagnoserne ”Forstyrrelse af aktivitet og opmærksomhed” og ”Opmærksomhedsforstyrrelse uden hyperaktivitet” i henhold til ICD-10. 2014 https://sundhedsstyrelsen.dk/da/nyheder/2014/~/media/A7931B11333540A184C73465181E29CE.ashx

^[750] Sundhedsstyrelsen og Apotekerforeningen. 2016

Seksårige forgiftes med ADHD-medicin. https://www.mx.dk/nyheder/danmark/story/24497913

^[751] Candy-flavored Amphetamines for children approved by the FDA. http://www.medicalmarijuanaupdate.com/2016-06-14-candy-flavored-amphetamines-for-children-approved-by-the-fda.html

^[752] Marijuana vs. Crystal Meth – A Funny (But True) Animation. https://herb.co/marijuana/news/marijuana-vs-crystal-meth-a-funny-but-true-animation

^[753] What are possible side effects of Adzenys XR-ODT? https://www.adzenysxrodt.com/about-adzenys/side-effects

^[754] How A Cannabis Oil Miracle Cure Became A Nightmare. https://herb.co/marijuana/news/cannabis-oil-miracle-2

^[755] Not-So-Shocking Results From Medical Cannabis Side-Effects Study. https://herb.co/marijuana/news/medical-cannabis-side-effects

The 3 Industries Killing Legal Weed. https://herb.co/marijuana/news/3-industries-killing-legal-weed

^[756] All In The Mind #1: Cannabis & ADD/ADHD. https://herb.co/marijuana/news/mind1-cannabis-addadhd

Hvorfor doper unge sig med ADHD-medicin? https://videnskab.dk/kultur-samfund/hvorfor-doper-unge-sig-med-adhd-medicin

Djøfs studielivsundersøgelse 2011. https://www.djoef.dk/presse-og-politik/forside/presse/pressemeddelelser/~/media/Documents/Djoef/S/Studielivsunders%C3%B8gelse%202011.ashx

Djøfs studielivsundersøgelse 2013. https://www.djoef.dk/~/media/documents/djoef/s/studielivsunders%C3%B8gelsen%202013.ashx

^[757] Seksårige forgiftes med ADHD-medicin. https://www.mx.dk/nyheder/danmark/story/24497913

Børn forgiftes af ADHD-medicin. https://nordjyske.dk/nyheder/boern-forgiftes-af-adhd-medicin/7d95d84d-3778-490f-b0cf-71b2ff13b307

^[758] Børn forgiftes af ADHD-medicin. https://nordjyske.dk/nyheder/boern-forgiftes-af-adhd-medicin/7d95d84d-3778-490f-b0cf-71b2ff13b307

^[759] Søren Dalsgaard, Anette Primdal Kvist, James F. Leckman et al.: Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder: A Nationwide Prospective Cohort Study. Journal of Child and Adolescent Psychopharmacology VOL. 24, NO. 6 | https://www.liebertpub.com/doi/full/10.1089/cap.2014.0020

ADHD-medicin til børn fordobler risiko for hjerteproblemer. https://videnskab.dk/krop-sundhed/adhd-medicin-til-born-fordobler-risiko-hjerte-problemer

^[760] ADHD-medicin til børn fordobler risiko for hjerteproblemer. https://videnskab.dk/krop-sundhed/adhd-medicin-til-born-fordobler-risiko-hjerte-problemer

^[761] ADHD-medicin giver ikke hjertelidelser. https://videnskab.dk/kort-nyt/adhd-medicin-giver-ikke-hjertelidelser

Laurel A. Habel, William O. Cooper, Colin M. Sox:  ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults. JAMA. 2011;306(24):2673-2683. doi:10.1001/jama.2011.1830.https://jamanetwork.com/journals/jama/fullarticle/1104778

^[762] Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad: Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies.

http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012069.pub2/full

Flere børn end antaget får bivirkninger af ADHD-medicin. https://videnskab.dk/krop-sundhed/flere-boern-end-antaget-faar-bivirkninger-af-adhd-medicin?utm_source=vores+nyhedsbrev&utm_campaign=2164ab950f-EMAIL_CAMPAIGN_2018_05_14&utm_medium=email&utm_term=0_d2f5c83eb4-2164ab950f-239989173

^[763] Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh et al.: Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009885.pub2/abstract

^[764] National klinisk retningslinje for udredning og behandling af ADHD hos børn og unge – med fokus på diagnoserne ”Forstyrrelse af aktivitet og opmærksomhed” og ”Opmærksomhedsforstyrrelse uden hyperaktivitet” i henhold til ICD-10. 2014 https://sundhedsstyrelsen.dk/da/nyheder/2014/~/media/A7931B11333540A184C73465181E29CE.ashx

^[765] Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh et al.:

 Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Developmental, Psychosocial and Learning Problems Group . Published Online: 25 NOV 2015. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009885.pub2/abstract;jsessionid=4F82FD7084DB65124472368F4542A509.f03t02

^[766] Forskere sår tvivl: ADHD-medicin til børn og unge virker ikke nødvendigvis. https://www.dr.dk/nyheder/indland/forskere-saar-tvivl-adhd-medicin-til-boern-og-unge-virker-ikke-noedvendigvis

^[767] Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh et al.: Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009885.pub2/abstract

^[768] Misbrug af Ritalin vokser markant. https://medicinsktidsskrift.dk/behandlinger/psykiatri/710-misbrug-af-ritalin-vokser-markant.html

^[769] Philippe Lucas,  Zach Walsh, Kim Crosby et al.: Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review Volume35, Issue3 May 2016 Pages 326-333. https://onlinelibrary.wiley.com/doi/abs/10.1111/dar.12323

^[770] Medical Marijuana Replaces Ritalin As Treatment For ADD & ADHD. https://medicalmarijuana411.com/marijuana-replaces-ritalin-in-treatment-for-addadhd/

se videoen Claudia Jensen talks Medical marijuana for ADD and Children https://www.youtube.com/watch?v=N6nq7a-syl8

^[771] Cannabis and ADHD – a Portrait. https://sensiseeds.com/en/blog/cannabis-and-adhd-a-portrait/

^[772] Bonni Goldstein. Cannabis Revealed. 2016

^[773] Centonze, D. et al.: Alterede anandamide degradation in attention-deficit/hyperactivity disorder. Neurology 72.17 (2009) 1526-1527. https://www.ncbi.nlm.nih.gov/pubmed/19398708

^[774] Lu, Ake T. et al.: Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. American Journal of medical genetics Part B: Neuropsychiatric Genetics 147.8 (2008): 1488-1494. https://www.ncbi.nlm.nih.gov/pubmed/18213623

^[775] Cannabis and ADD/ADHD. https://www.leafly.com/news/health/cannabis-and-addadhd

^[776] Wie hilft Cannabis bei ADHS? http://www.alternative-drogenpolitik.de/2016/02/03/wie-hilft-cannabis-bei-adhs/#comment-521501

^[777] Cannabis: a plant with many faces. https://sensiseeds.com/en/blog/cannabis-plant-many-faces/

^[778] Cannabis: a plant with many faces. https://sensiseeds.com/en/blog/cannabis-plant-many-faces/

^[779] Marijuana and ADHD. https://www.leafscience.com/2017/11/21/marijuana-and-adhd/

What Are The Medical Benefits of CBD?https://www.leafscience.com/2017/12/06/medical-benefits-cbd/

^[780] Gururajan A¹, Taylor DA, Malone DT: Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats. J Psychopharmacol. 2012 Oct;26(10):1317-32. doi: 10.1177/0269881112441865. Epub 2012 Apr 9. https://www.ncbi.nlm.nih.gov/pubmed/22495620

^[781] Sweet Dreams #2: How Cannabis Affects Deep Sleep. https://herb.co/marijuana/news/cannabis-affects-deep-sleep

^[782] https://www.ted.com/talks/jeff_iliff_one_more_reason_to_get_a_good_night_s_sleep/transcript?language=en

^[783] The Odd Science Behind Marijuana And Metabolism. https://herb.co/marijuana/news/odd-science-behind-marijuana-metabolism

^[784] Marinol VS THC: What’s The Difference? https://herb.co/marijuana/news/marinol-vs-thc-whats-difference

^[785] Stephen E. Sallan, Norman E. Zinberg, Emil Frei: Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy. N Engl J Med 1975; 293:795-797October 16, 1975DOI: 10.1056/NEJM197510162931603. http://www.nejm.org/doi/pdf/10.1056/NEJM197510162931603

^[786] The Effects Of Weed On Your Health. https://herb.co/marijuana/news/the-effects-of-weed-on-your-health

^[787] Cooper RE¹, Williams E², Seegobin S. et al.: Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Eur Neuropsychopharmacol. 2017 Aug;27(8):795-808. doi: 10.1016/j.euroneuro.2017.05.005. Epub 2017 May 30. https://www.ncbi.nlm.nih.gov/pubmed/28576350

Mallory Loflin, Mitch Earleywine, Joseph De Leo et al.: Subtypes of Attention Deficit-Hyperactivity Disorder (ADHD) and Cannabis Use. Substance Use & Misuse Volume 49, 2014 – Issue 4 . http://www.tandfonline.com/doi/full/10.3109/10826084.2013.841251?scroll=top&needAccess=true

^[788] Peter Strohbeck-Kuehner, Gisela Skopp, Rainer Mattern: Cannabis improves symptoms of ADHD. Case report. Institute of Legal- and Traffic Medicine, Heidelberg University Medical Centre, Voss Str. 2, D-69115 Heidelberg, Germany. Cannabinoids 2008;3(1):1-3. http://www.cannabis-med.org/english/journal/en_2008_01_1.pdf

^[789] Nieoullon A¹.: Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002 May;67(1):53-83. https://www.ncbi.nlm.nih.gov/pubmed/12126656

Cooper RE¹, Williams E², Seegobin S. et al.: Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Eur Neuropsychopharmacol. 2017 Aug;27(8):795-808. doi: 10.1016/j.euroneuro.2017.05.005. Epub 2017 May 30. https://www.ncbi.nlm.nih.gov/pubmed/28576350

(ASTONISHING): Psychological Effects of Marijuana. https://herb.co/2015/08/13/astonishing-psychological-effects-of-marijuana/

^[790] Erik B. Oleson, Joseph F. Cheer: A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking. http://perspectivesinmedicine.cshlp.org/content/current

HOW DRUGS AFFECT NEUROTRANSMITTERS. http://thebrain.mcgill.ca/flash/i/i_03/i_03_m/i_03_m_par/i_03_m_par_cannabis.html

^[791] Eva Milz1, Franjo Grotenhermen: SUCCESSFUL THERAPY OF TREATMENT RESISTANT ADULT ADHD WITHCANNABIS: EXPERIENCE FROM A MEDICAL PRACTICE WITH 30 PATIENTS. Medical Practice for Psychiatry and Psychotherapy, Berlin, Germany; 2Nova-Institute Hürth/Rheinland, Germany; 3Medical Practice, Rüthen, Germany. http://cannabisclinicians.org/wp-content/uploads/2016/02/SUCCESSFUL-THERAPY-OF-TREATMENT-RESISTANT-ADULT-ADHD-WITH-CANNABIS.pdf

^[792] Peter Strohbeck-Kuehner, Gisela Skopp, Rainer Mattern: Cannabis improves symptoms of ADHD. Cannabinoids 2008;3(1):1-3. http://www.cannabis-med.org/english/journal/en_2008_01_1.pdf

Nieoullon A¹.: Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002 May;67(1):53-83. https://www.ncbi.nlm.nih.gov/pubmed/12126656

^[793] Russo EB: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters [01 Feb 2004, 25(1-2):31-39]. http://europepmc.org/abstract/med/15159679

The Endocannabinoid System: A Beginner’s Guide. https://www.leafscience.com/2017/03/17/the-endocannabinoid-system-a-beginners-guide/

^[794] Women and ADHD. https://www.webmd.com/add-adhd/features/adhd-in-women#1

All In The Mind #1: Cannabis & ADD/ADHD . https://herb.co/2016/06/08/mind1-cannabis-addadhd/

^[795] Marijuana Could Replace These 5 Prescription Pills. https://herb.co/marijuana/news/marijuana-could-replace-these-5-prescription-pills

^[796] Kolla NJ^1,2,3, van der Maas M^4,5, Toplak ME. Et al.: Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey. BMC Psychiatry. 2016 Feb 27;16:50. doi: 10.1186/s12888-016-0746-4. https://www.ncbi.nlm.nih.gov/pubmed/26920911

^[797] Ly C¹, Gehricke JG.: Marijuana use is associated with inattention in men and sleep quality in women with Attention-Deficit/Hyperactivity Disorder: a preliminary study. Psychiatry Res. 2013 Dec 30;210(3):1310-2. doi: 10.1016/j.psychres.2013.08.003. Epub 2013 Aug 29. https://www.ncbi.nlm.nih.gov/pubmed/23993465

(ASTONISHING): Psychological Effects of Marijuana. https://herb.co/2015/08/13/astonishing-psychological-effects-of-marijuana/

^[798] Clare Kelly, F. Xavier Castellanos,Olivia Tomaselli et al.: Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. Neuroimage Clin. 2017; 13: 188–200.

Published online 2016 Sep 15. doi:  10.1016/j.nicl.2016.09.012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153452/

^[799] Daniel P. Notzon,^1,2 Martina Pavlicova,² Andrew Glass et al.: ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord. : 1087054716640109.

Published online 2016 Mar 31. doi:  10.1177/1087054716640109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568505/

^[800] Breyer JL¹, Lee S², Winters KC et al.: A longitudinal study of childhood ADHD and substance dependence disorders in early adulthood. Psychol Addict Behav. 2014 Mar;28(1):238-46. doi: 10.1037/a0035664. https://www.ncbi.nlm.nih.gov/pubmed/24731117

^[801] Sibley MH¹, Pelham WE², Molina BSG. Et al.: The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use. J Abnorm Psychol. 2014 May;123(2):362-374. doi: 10.1037/a0036585. https://www.ncbi.nlm.nih.gov/pubmed/24886010

^[802] Jacobus J, Tapert SF.: Effects of cannabis on the adolescent brain. Curr Pharm Des. 2014;20(13):2186-93. https://www.ncbi.nlm.nih.gov/pubmed/23829363

^[803] Leanne Tamm, Jeffery N. Epstein, Krista M. Lisdahl et al.: Impact of ADHD and Cannabis Use on Executive Functioning in Young Adults. Drug Alcohol Depend. 2013 Dec 1; 133(2): 10.1016/j.drugalcdep.2013.08.001.

Published online 2013 Aug 11. doi:  10.1016/j.drugalcdep.2013.08.001

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820098/

^[804] Krista M. Lisdahl,^1,* Leanne Tamm,² Jeffery N. Epstein et al.: The Impact of ADHD Persistence, Recent Cannabis Use, and Age of Regular Cannabis Use Onset on Subcortical Volume and Cortical Thickness in Young Adults.Drug Alcohol Depend. 2016 Apr 1; 161: 135–146.

Published online 2016 Feb 6. doi:  10.1016/j.drugalcdep.2016.01.032

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289096/

^[805] How to Use Medical Cannabis. https://www.marijuanadoctors.com/resources/methods-medicating-cannabis/

^[806] Autisme. https://faktalink.dk/titelliste/auti

^[807] How Cannabis and CBD Offer Hope in Future Treatments of Autism. https://www.leafly.com/news/health/cannabis-cbd-autism-treatment  

Happé F¹, Ronald A, Plomin R.: Time to give up on a single explanation for autism. Nat Neurosci. 2006 Oct;9(10):1218-20. https://www.ncbi.nlm.nih.gov/pubmed/17001340

^[808] Eric M. Roberts,¹ Paul B. English,² Judith K. Grether et al.: Maternal Residence Near Agricultural Pesticide Applications and Autism Spectrum Disorders among Children in the California Central Valley. Environ Health Perspect. 2007 Oct; 115(10): 1482–1489. Published online 2007 Jul 30. doi:  10.1289/ehp.10168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2022638/

^[809] Florence I.Roullet, Jonathan K.Y., LaiJane A.Foster: In utero exposure to valproic acid and autism — A current review of clinical and animal studies. Neurotoxicology and Teratology Volume 36, March–April 2013, Pages 47-56.https://www.sciencedirect.com/science/article/pii/S0892036213000056

^[810]

Maureen S. Durkin, Matthew J. Maenner, Craig J. Newschaffer et al.: Advanced Parental Age and the Risk of Autism Spectrum Disorder. American Journal of Epidemiology, Volume 168, Issue 11, 1 December 2008, Pages 1268–1276, https://doi.org/10.1093/aje/kwn250. https://academic.oup.com/aje/article/168/11/1268/121274

Caroline E. Robertson, Eva-Maria Ratai, Nancy Kanwisher et al.:: Reduced GABAergic Action in the Autistic Brain. Current Biology Volume 26, Issue 1, p80–85, 11 January 2016. https://www.cell.com/current-biology/fulltext/S0960-9822(15)01413-X 

^[811] Dit indre liv med billioner af bakterier. Løkken Kulturhus 23. oktober 2018. Livestream foredrag af genomforsker Oluf B. Pedersen Aarhus Universitet.

^[812] Information om autisme hos børn og unge. Diagnosen, indsatser og livskvalitet. http://www.psykiatrien.rm.dk/siteassets/patient/information-om-psykiske-sygdomme/nar-du-er-barn-eller-ung/autisme/72194-ds-autisme-hos-born-og-unge1.01_webforsog.pdf

^[813] Bo Hoon Lee, Tristram Smith, Alex R. Paciorkowski: Autism Spectrum Disorder and Epilepsy: disorders with a shared biology. Epilepsy Behav. 2015 June ; 47: 191–201. doi:10.1016/j.yebeh.2015.03.017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475437/pdf/nihms683332.pdf

^[814] Elina Jokiranta, Andre Sourander, Auli Suominen: Epilepsy Among Children and Adolescents with Autism Spectrum Disorders: A Population-Based Study. Journal of Autism and Developmental Disorders

October 2014, Volume 44, Issue 10, pp 2547–2557. https://link.springer.com/article/10.1007%2Fs10803-014-2126-6

^[815] Part One: The Endocannabinoid System and Autism Spectrum Disorder (ASD). http://www.medicaljane.com/2015/06/17/is-the-endocannabinoid-system-involved-in-the-progression-of-asd/

The Importance of Enhancing Your Endocannabinoid System. https://www.medicaljane.com/2015/03/11/the-importance-of-enhancing-your-endocannabinoid-system/

^[816] Alger, Bradley. Getting High on the Endocannabinoid System. Cerebrum. 2013 Nov-Dec; 2013: 14. Published online 2013 Nov 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/

^[817] Pacher, Pál, Sándor Bátkai, and George Kunos. “The endocannabinoid system as an emerging target of pharmacotherapy.” Pharmacological reviews 58.3 (2006): 389-462. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/

^[818] Cannabis for Pediatric Autism. http://bayareacannabis.com/cannabis-for-pediatric-autism/

^[819] Goldstein, Bonni: Cannabis Revealed. 2016.

^[820] Mauro Maccarrone,^1,2,* Silvia Rossi,^2,3 Monica Bari et al.: Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA. Neuropsychopharmacology. 2010 Jun; 35(7): 1500–1509.

Published online 2010 Mar 10. doi:  [10.1038/npp.2010.19]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055456/

^[821] Kwang-Mook Jung, Marja Sepers,Christopher M. Henstridge et al.: Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun. 2012 Sep 25; 3: 1080.

Published online 2012 Sep 25. doi:  [10.1038/ncomms2045.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657999/

^[822] Schultz ST.: Can autism be triggered by acetaminophen activation of the endocannabinoid system? Acta Neurobiol Exp (Wars). 2010;70(2):227-31. https://www.ncbi.nlm.nih.gov/pubmed/20628445

^[823] Kerr DM¹, Downey L, Conboy M. et al.: Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav Brain Res. 2013 Jul 15;249:124-32. doi: 10.1016/j.bbr.2013.04.043. Epub 2013 May 1. https://www.ncbi.nlm.nih.gov/pubmed/23643692

^[824] Siniscalco D¹, Sapone A, Giordano C. et al.: Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord. 2013 Nov;43(11):2686-95. doi: 10.1007/s10803-013-1824-9. https://www.ncbi.nlm.nih.gov/pubmed/23585028

^[825] Csaba Földy, Robert C. Malenka, Thomas C. Südhof et al.: Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling. Neuron Volume 78, Issue 3, p498–509, 8 May 2013 . http://www.cell.com/neuron/abstract/S0896-6273%2813%2900225-0

^[826]  Kurz R, Blass K. Use of dronabinol (delta-9-THC) in autism: a prospective single-case-study with an early infantile autistic child. Cannabinoids. 2010; 5( 4): 4– 6. http://irka.org.rs/wp-content/uploads/2014/09/Use-of-dronabinol-delta-9-THC-in-autism.pdf

^[827] Kruger T, Christophersen E. An open label study of the use of dronabinol (marinol) in the management of treatment-resistant self-injurious behavior in 10 retarded adolescent patients. J Dev Behav Pediatr. 2006;27( 5): 433.

^[828] Marijuana-Like Chemical May Help Autism And Fragile X Syndrome Symptoms. http://www.huffingtonpost.com/2012/09/27/marijuana-chemical-autism-fragile-x_n_1920320.html

^[829] How Does Your Endocannabinoid System Impact Your Brain’s Response to Social Interaction? https://www.leafly.com/news/science-tech/how-does-your-endocannabinoid-system-impact-your-brains-response

How Does Cannabis Consumption Affect Autism? https://www.leafly.com/news/health/how-does-cannabis-consumption-affect-autism

^[830] Cannabis for Pediatric Autism. http://www.marijuana.com/blog/news/2017/02/cannabis-for-pediatric-autism/

^[831] Will This State Legalize Medical Marijuana For Autism Patients? https://herb.co/marijuana/news/pa-set-legalize-medical-marijuana-autism

^[832] Kurz, René, and Kurt Blaas. “Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child.” Cannabinoids 5 (2010): 4-6.

^[833] http://www.miekosblog.com/

^[834] Cannabis-Infused Edibles 101: What to Know About Dosing, Potency, and Labeling. https://www.leafly.com/news/cannabis-101/medibles-101-everything-youve-ever-wanted-to-know-about-edibles

^[835] How Does Cannabis Consumption Affect Autism? https://www.leafly.com/news/health/how-does-cannabis-consumption-affect-autism

THC: Everything You Need To Know About Delta9-Tetrahydrocannabinol. https://herb.co/marijuana/news/what-is-thc

^[836] Mom Overjoyed: “Medical Marijuana Saved My Son’s Life” https://herb.co/marijuana/news/mom-overjoyed-medical-marijuana-saved-my-sons-life

https://www.youtube.com/watch?v=QP4ZoKgxyUo

^[837] Parents of autistic boy,11, give him medical marijuana to curb his self-destructive rages. https://www.dailymail.co.uk/news/article-2272036/Portland-boy-Alex-Echols-11-autism-gets-medical-marijuana-curb-self-destructive-rages.html

Alex’s Story: How Desperate Parents Used Medical Marijuana to Combat Autistic Rage. https://www.buzzworthy.com/alex-medical-marijuana-used-to-combat-autistic-rage/

^[838] https://www.mammausa.org/

^[839] Will This State Legalize Medical Marijuana For Autism Patients? https://herb.co/marijuana/news/pa-set-legalize-medical-marijuana-autism

^[840] Israeli activist and mother Abigail Dar shares her struggle to spread relief with cannabis oil. https://merryjane.com/culture/autism-cannabis-oil-research-abigail-dar-interview

^[841] IS MARIJUANA THE WORLD’S MOST EFFECTIVE TREATMENT FOR AUTISM? http://www.newsweek.com/2018/02/23/really-good-weed-why-cannabis-may-be-worlds-most-effective-remedy-core-806758.html

^[842] New Hope As Doctors Begin Treating Autism With Cannabis. https://herb.co/2016/09/02/autism/

^[843] In pioneering study, Israeli researchers target autism with cannabis. http://www.timesofisrael.com/in-pioneering-study-israeli-researchers-target-autism-with-cannabis/

http://www.videnomcannabis.dk/?pid=210

^[844] In Israel, booming medical marijuana looks to conquer new highs. http://www.timesofisrael.com/in-israel-booming-medical-marijuana-looks-to-conquer-new-highs/

^[845] Australian Biotech Company Wants to Treat Autism Symptoms With Cannabis https://www.leafly.com/news/health/australian-biotech-company-wants-to-treat-autism-symptoms-with-cannabis

^[846] Part Two: The Role of Phytocannabinoids in ASD Therapy. https://www.medicaljane.com/2015/06/17/part-two-the-role-of-phytocannabinoids-in-asd-therapy/#citation-34

^[847] Pertwee, R. G., et al. “International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2.” Pharmacological reviews 62.4 (2010): 588-631.

^[848] Russo, Ethan B. “Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects.” British Journal of Pharmacology 163.7 (2011): 1344-1364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/

^[849] Hazekamp, Arno, and Franjo Grotenhermen. “Clinical Studies With Cannabis and Cannabinoids, 2005-2009.” (2013). http://www.beyondthc.com/wp-content/uploads/2013/08/HazekampGrotenhermen-2010.pdf

^[850] Jiang, Wen, et al. “Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects.” Journal of Clinical Investigation11 (2005): 3104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1253627/

Avraham, Hava Karsenty, et al. “The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.” British journal of pharmacology2 (2014): 468-479. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/

Campos, Alline Cristina, et al. “Multiple mechanisms involved in the largespectrum therapeutic potential of cannabidiol in psychiatric disorders.” Philosophical Transactions of the Royal Society B: Biological Sciences 367.1607 (2012): 3364-3378. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/

^[851] Hampson, Aidan J., Julius Axelrod, and Maurizio Grimaldi. “Cannabinoids as antioxidants and neuroprotectants.” U.S. Patent No. 6,630,507. 7 Oct. 2003. https://patents.google.com/patent/US6630507B1/en

Lara-Celador, I. et al. “Using the Endocannabinoid System as a Neuroprotective Strategy in Perinatal Hypoxic-Ischemic Brain Injury.” Neural Regeneration Research8 (2013): 731–744. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/

Sanchez, A. J., and A. Garcia-Merino. “Neuroprotective agents: cannabinoids.” Clinical Immunology1 (2012): 57-67. https://www.ncbi.nlm.nih.gov/pubmed/21420365

^[852] Borges, Rosivaldo S., et al. “Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.” Molecules10 (2013): 12663-12674. https://www.ncbi.nlm.nih.gov/pubmed/24129275

Hampson, Aidan J., Julius Axelrod, and Maurizio Grimaldi. “Cannabinoids as antioxidants and neuroprotectants.” U.S. Patent No. 6,630,507. 7 Oct. 2003. https://patents.google.com/patent/US6630507B1/en

^[853] Davis, Mellar, et al. “The emerging role of cannabinoid neuromodulators in symptom management.” Supportive care in cancer1 (2007): 63-71. https://www.researchgate.net/publication/6660412_The_emerging_role_of_cannabinoid_neuromodulators_in_symptom_management

Lara-Celador, I. et al. “Using the Endocannabinoid System as a Neuroprotective Strategy in Perinatal Hypoxic-Ischemic Brain Injury.” Neural Regeneration Research8 (2013): 731–744. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/

Youssef, F. F., and A. J. Irving. “From cannabis to the endocannabinoid system: refocussing attention on potential clinical benefits.” West Indian Medical Journal 61.3 (2012). https://www.ncbi.nlm.nih.gov/pubmed/23155985

^[854] Pertwee, R. G., et al. “International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2.” Pharmacological reviews 62.4 (2010): 588-631. https://www.ncbi.nlm.nih.gov/pubmed/21079038

Izzo, Angelo A., et al. “Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.” Trends in pharmacological sciences 30.10 (2009): 515-527. https://www.ncbi.nlm.nih.gov/pubmed/19729208

^[855] Camilleri, Michael, et al. “Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.” American Journal of Physiology Gastrointestinal and Liver Physiology 304.5 (2013): G553-G560. https://www.ncbi.nlm.nih.gov/pubmed/23306084

Di Sabatino, A., et al. “The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.” Mucosal immunology 4.5 (2011): 574-583. https://www.ncbi.nlm.nih.gov/pubmed/21471961

Wright, K. L., M. Duncan, and K. A. Sharkey. “Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.” British journal of pharmacology 153.2 (2008): 263-270. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/

^[856] Casarotto, Plinio C., et al. “Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors.” Behavioural pharmacology 21.4 (2010): 353-358. https://www.ncbi.nlm.nih.gov/pubmed/20695034

Deiana, Serena, et al. “Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), ∆9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour.” Psychopharmacology 219.3 (2012): 859-873. https://www.ncbi.nlm.nih.gov/pubmed/21796370

Gomes, Felipe V., et al. “Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.” Progress in NeuroPsychopharmacology and Biological Psychiatry 35.2 (2011): 434-438. https://www.ncbi.nlm.nih.gov/pubmed/21111767

^[857] Jones, Nicholas A., et al. “Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.” Seizure 21.5 (2012): 344-352. https://www.ncbi.nlm.nih.gov/pubmed/22520455

Porter, Brenda E., and Catherine Jacobson. “Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.” Epilepsy & Behavior 29.3 (2013): 574-577. https://www.ncbi.nlm.nih.gov/pubmed/24237632

van Rijn, Clementina M., et al. “Endocannabinoid system protects against cryptogenic seizures.” Pharmacol Rep 63 (2011): 165-168. https://www.researchgate.net/publication/50868073_Endocannabinoid_system_protects_against_cryptogenic_seizures

^[858] Ware, Mark A., et al. “The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.” Anesthesia & Analgesia 110.2 (2010): 604-610. https://www.ncbi.nlm.nih.gov/pubmed/20007734

Murillo-Rodriguez, Eric, et al. “The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.” Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Central Nervous System Agents) 11.3 (2011): 189-196. https://www.ncbi.nlm.nih.gov/pubmed/21919868

^[859] Müller-Vahl, K. R., et al. “Cannabis in movement disorders.” Forschende Komplementärmedizin/Research in Complementary Medicine 6.Suppl. 3 (2004): 23-27. https://www.ncbi.nlm.nih.gov/pubmed/10627163

Onaivi, E. S., et al. “Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders.” Current Neuropharmacology 9.1 (2011): 209. https://www.ncbi.nlm.nih.gov/pubmed/21886592

Passie, Torsten, et al. “Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence.” Drug testing and analysis7-8 (2012): 649-659. https://www.ncbi.nlm.nih.gov/pubmed/22736575

^[860] Krueger, Dilja D., and Nils Brose. “Evidence for a common endocannabinoidrelated pathomechanism in autism spectrum disorders.” Neuron 78.3 (2013): 408410. https://www.sciencedirect.com/science/article/pii/S0896627313003619

Shu, Hai-Feng, et al. “Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.” Brain and Development 35.3 (2013): 252-260. https://www.ncbi.nlm.nih.gov/pubmed/22647236

Zurolo, E., et al. “CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.” Neuroscience 170.1 (2010): 28-41. https://www.ncbi.nlm.nih.gov/pubmed/20621164

^[861] Schmidt, W., et al. “Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.” Neuroscience 227 (2012): 313-326. https://www.ncbi.nlm.nih.gov/pubmed/23069763

Choi, In-Young, et al. “Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury.” The American journal of pathology 182.3 (2013): 928-939. https://www.ncbi.nlm.nih.gov/pubmed/23414569

Murikinati, Sasidhar, et al. “Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment.” The FASEB journal 24.3 (2010): 788-798. https://www.ncbi.nlm.nih.gov/pubmed/23414569

Garcia-Bonilla, Lidia, et al. “Immune mechanisms in cerebral ischemic tolerance.” Frontiers in neuroscience 8 (2014). https://www.frontiersin.org/articles/10.3389/fnins.2014.00044/full

^[862] Hill, Matthew N., and Boris B. Gorzalka. “The endocannabinoid system and the treatment of mood and anxiety disorders.” CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 8.6 (2009): 451-458. https://www.ncbi.nlm.nih.gov/pubmed/19839936

Almeida, Valeria, et al. “Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test.” Progress in NeuroPsychopharmacology and Biological Psychiatry 41 (2013): 30-35. https://www.ncbi.nlm.nih.gov/pubmed/23127569

Schier, Alexandre Rafael de Mello, et al. “Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.” Revista Brasileira de Psiquiatria 34 (2012): 104-110. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008

^[863] Engeli, Stefan. “Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.” Appetite Control. Springer Berlin Heidelberg, 2012. 357-381. https://www.ncbi.nlm.nih.gov/pubmed/22249824

Marco, Eva M., et al. “The role of the endocannabinoid system in eating disorders: pharmacological implications.” Behavioural pharmacology 23.5 and 6 (2012): 526-536. https://www.theroc.us/researchlibrary/The%20role%20of%20the%20endocannabinoid%20system%20in%20eating%20disorders-%20pharmacological%20implications.pdf

^[864] McPartland, John M., and Ethan B. Russo. “Cannabis and cannabis extracts: greater than the sum of their parts?.” Journal of Cannabis Therapeutics 1.3-4 (2001): 103-132. https://www.researchgate.net/publication/228897917_Cannabis_and_cannabis_extracts_Greater_than_the_sum_of_their_parts

Izzo, Angelo A., et al. “Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.” Trends in pharmacological sciences 30.10 (2009): 515-527. https://www.ncbi.nlm.nih.gov/pubmed/19729208

^[865] Gertsch, Jürg, Roger G. Pertwee, and Vincenzo Di Marzo. “Phytocannabinoids beyond the Cannabis plant–do they exist?” British journal of pharmacology 160.3 (2010): 523-529. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/

^[866] Russo, Ethan B. “Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects.” British Journal of Pharmacology 163.7 (2011): 1344-1364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/

^[867] Kurz, René, and Kurt Blaas. “Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child.” (2010)

^[868] Lester Grinspoon: A Novel Approach to the Symptomatic Treatment of Autism. http://www.beyondthc.com/wp-content/uploads/2013/08/GrinspoonAutism.pdf

^[869] How Does Cannabis Consumption Affect Autism? https://www.leafly.com/news/health/how-does-cannabis-consumption-affect-autism

^[870] Marijuana and muscle spasms. https://herb.co/news/health/marijuana-and-muscle-spasms/

^[871] Cannabis in the Treatment of Pediatric Epilepsy. http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[872] Hvad er epilepsi? og andre ofte stillede spørgsmål. https://www.epilepsiforeningen.dk/epilepsi/?gclid=EAIaIQobChMIx9iyzqnE3gIVgc13Ch2BtQgpEAAYASAAEgIGoPD_BwE

^[873] Hvad er epilepsi? og andre ofte stillede spørgsmål. https://www.epilepsiforeningen.dk/epilepsi/?gclid=EAIaIQobChMIx9iyzqnE3gIVgc13Ch2BtQgpEAAYASAAEgIGoPD_BwE

^[874] Langtidsbivirkninger av antiepileptika. https://tidsskriftet.no/2016/02/klinisk-oversikt/langtidsbivirkninger-av-antiepileptika

Valproat øger risikoen for at børn bliver bogligt svage. https://www.epilepsiforeningen.dk/nyheder/valproat-oeger-risikoen-boern-bogligt-svage/

^[875] Epilepsy. https://www.mayoclinic.org/diseases-conditions/epilepsy/symptoms-causes/syc-20350093

^[876] Brugere og bivirkninger af antiepileptika i Danmark. Sundhedsstyrelsen, 2014. https://laegemiddelstyrelsen.dk/da/udgivelser/2014/brugere-og-bivirkninger-af-antiepileptika-i-danmark/~/media/844760D6CB13445CAE54BCDE8F29A4B2.ashx

^[877] Epilepsy drugs increase people’s risk of dementia by up to 60% by breaking down brain cells. http://americanhealthnews.info/epilepsy-drugs-increase-peoples-risk-of-dementia-by-up-to-60-by-breaking-down-brain-cells/

Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009: 72(14): 1223-9.

^[878] Øger epilepsimedicin risikoen for demens? https://www.epilepsiforeningen.dk/nyheder/oeger-epilepsimedicin-risikoen-demens/

^[879] Valproat-farer er velkendte. https://www.epilepsiforeningen.dk/nyheder/valproat-farer-er-velkendte/

^[880] Byron J. Richards: Neurontin and Lyrica are a Death Sentence for New Brain Synapses. https://www.wellnessresources.com/news/neurontin-and-lyrica-are-a-death-sentence-for-new-brain-synapses

^[881] Neurontin and Lyrica are a Death Sentence for New Brain Synapses: The Saga Continue http://usmedtimes.com/2017/12/01/neurontin-lyrica-death-sentence-new-brain-synapses-saga-continue/

^[882] Neurontin and Lyrica Adverse Effects – The Saga Continues. https://www.wellnessresources.com/news/neurontin-and-lyrica-adverse-effects-the-saga-continues

^[883] Çagla Eroglu,^†* Nicola J. Allen,^† Michael W. Susman et al.: The Gabapentin Receptor α2δ-1 is the Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis. Cell. Author manuscript; available in PMC 2010 Apr 16. Published in final edited form as:

Cell. 2009 Oct 16; 139(2): 380–392.  Published online 2009 Oct 8. doi:  [10.1016/j.cell.2009.09.025] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791798/

^[884] Pfizer Ponies Up $2.3 Billion for Drug Crimes. https://www.wellnessresources.com/news/pfizer-ponies-up-23-billion-for-drug-crimes

^[885] Stannard C.: Misuse of gabapentin and pregabalin: a marker for a more serious malaise? Addiction. 2016 Oct;111(10):1699-700. doi: 10.1111/add.13408. Epub 2016 Jul 25. https://www.ncbi.nlm.nih.gov/pubmed/27454743

^[886] Evoy KE^1,2, Morrison MD³, Saklad SR.: Abuse and Misuse of Pregabalin and Gabapentin. Drugs. 2017 Mar;77(4):403-426. doi: 10.1007/s40265-017-0700-x. https://www.ncbi.nlm.nih.gov/pubmed/28144823

^[887] Winterfeld U¹, Merlob P², Baud D. et al.: Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology. 2016 Jun 14;86(24):2251-7. doi: 10.1212/WNL.0000000000002767. Epub 2016 May 18.https://www.ncbi.nlm.nih.gov/pubmed/27194385

^[888] Etemad L¹, Jafarian AH, Moallem SA.: Pathogenesis of Pregabalin-Induced Limb Defects in Mouse Embryos. J Pharm Pharm Sci. 2015;18(5):882-9. https://www.ncbi.nlm.nih.gov/pubmed/26670374

^[889] Winterfeld U¹, Merlob P², Baud D. et al.: Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology. 2016 Jun 14;86(24):2251-7. doi: 10.1212/WNL.0000000000002767. Epub 2016 May 18.https://www.ncbi.nlm.nih.gov/pubmed/27194385

^[890] Zaccara G¹, Giovannelli F^1,2, Giorgi FS. Et al.: Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies.

^[891] Moshiri M¹, Moallem SA², Attaranzadeh A.: Injury to skeletal muscle of mice following acute and sub-acute pregabalin exposure. Iran J Basic Med Sci. 2017 Mar;20(3):256-259. doi: 10.22038/ijbms.2017.8352. https://www.ncbi.nlm.nih.gov/pubmed/28392896

^[892] Peter Jonas, John Lisman: Structure, function, and plasticity of hippocampal dentate gyrus microcircuits. Front Neural Circuits. 2014; 8: 107. Published online 2014 Sep 10. doi:  10.3389/fncir.2014.00107. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159971/

^[893] Tibor Hajszan, Antonia Dow, Jennifer L.: Remodeling of Hippocampal Spine Synapses in the Rat Learned Helplessness Model of Depression. Biological Psychiatry 2009 March Yale University. https://www.wellnessresources.com/studies/stress-adversely-effects-nerve-cell-connections

^[894] Zaccara G¹, Giovannelli F^1,2, Giorgi FS. Et al.: Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. Br J Clin Pharmacol. 2017 Sep;83(9):1873-1879. doi: 10.1111/bcp.13296. Epub 2017 May 7. https://www.ncbi.nlm.nih.gov/pubmed/28370224

^[895] Kato K¹, Iwasaki Y², Onodera K³, Higuchi M. et al.: Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case report. Int J Surg Case Rep. 2016;26:221-3. doi: 10.1016/j.ijscr.2016.07.007. Epub 2016 Jul 14. https://www.ncbi.nlm.nih.gov/pubmed/27521491

^[896] Mitochondria – Drugs that Injure and What Mitochondria Injury Looks Like. https://www.wellnessresources.com/news/mitochondria-drugs-that-injure-and-what-mitochondria-injury-looks-like

^[897] Agarwal N¹, Singh S¹, Kriplani A. et al.: Safety and efficacy of gabapentin in management of psychosomatic and sexual symptoms in postmenopausal women: A pilot study. J Midlife Health. 2015 Jan-Mar;6(1):10-5. doi: 10.4103/0976-7800.153605. https://www.ncbi.nlm.nih.gov/pubmed/25861202

^[898] Piovezan RD¹, Kase C¹, Moizinho R. et al.: Gabapentin acutely increases the apnea-hypopnea index in older men: data from a randomized, double-blind, placebo-controlled study. J Sleep Res. 2017 Apr;26(2):166-170. doi: 10.1111/jsr.12495. Epub 2017 Jan 24. https://www.ncbi.nlm.nih.gov/pubmed/28116804

Quintero GC.: Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol. 2017 Feb 9;9:13-21. doi: 10.2147/JEP.S124391. eCollection 2017. https://www.ncbi.nlm.nih.gov/pubmed/28223849

^[899] Kibar S¹, Demir S¹, Sezer N. et al.: Gabapentin-Induced Urinary Incontinence: A Rare Side Effect in Patients with Neuropathic Pain. Case Rep Neurol Med. 2015;2015:341573. doi: 10.1155/2015/341573. Epub 2015 Aug 16. https://www.ncbi.nlm.nih.gov/pubmed/26351600

^[900] CBD User’s Manual https://www.projectcbd.org/article/cbd-users-manual-0

^[901] A Brief History And Outlook Of Cannabis Extract Medicine. https://www.medicaljane.com/2013/12/06/a-brief-history-outlook-of-cannabis-extract-medicine/

Cannabis Extract Medicine Begins To Take Hold Worldwide. https://www.medicaljane.com/2014/03/15/cannabis-extract-medicine-begins-to-take-hold-worldwide/

^[902] The Rising Use of Cannabis Extract Medicine in Australia. https://www.medicaljane.com/2014/02/02/the-rising-use-of-cannabis-extract-medicine-in-australia/

^[903] Ireland Is One Step Closer To Legalizing Medical Cannabis. https://herb.co/marijuana/news/ireland-medical-cannabis-2

^[904] Children and Marijuana #2: Conditions Treated With Cannabis https://herb.co/marijuana/news/children-treated-cannabis

^[905] One Man’s Desperate Quest to Cure His Son’s Epilepsy—With Weed. https://www.wired.com/2015/07/medical-marijuana-epilepsy/

^[906] GW Pharmaceuticals Value Doubles After Successful Clinical Trials Results. https://herb.co/marijuana/news/cannabis-drug-successfully-treats-epilepsy-gw-pharmaceuticals-value-doubles

Will The FDA Approve New Cannabis-Extract Epilepsy Drug For Kids? https://herb.co/marijuana/news/fda-cannabis-epilepsy-drug

^[907] Seneste nyt: Cannabis-olie hjælper børn med epilepsi.

https://propatienter.dk/sygdomme/hjernen/248-cannabis-olie-hjaelper-born-med-epilepsi.html

^[908] Epilepsiramte Nicolai har fået det bedre efter lægen gav ham cannabis.

https://www.dr.dk/nyheder/indland/epilepsiramte-nicolai-har-faaet-det-bedre-efter-laegen-gav-ham-cannabis

^[909] Otte-årige Valentin har skiftet 17 daglige piller ud med få dråber cannabisolie. https://stiften.dk/norddjurs/Otte-aarige-Valentin-har-skiftet-17-daglige-piller-ud-med-faa-draaber-cannabisolie/artikel/475951

^[910] https://www.youtube.com/watch?v=Z3IMfIQ_K6U

^[911] Marijuana stops child’s severe seizures. http://edition.cnn.com/2013/08/07/health/charlotte-child-medical-marijuana/

Charlotte’s Web: The One Story Driving Medical Marijuana Legalization. https://herb.co/marijuana/news/charlottes-web-the-one-story-driving-medical-marijuana-legalization

^[912] How are Charlotte’s Web products created? Find out with this fascinating video! https://herb.co/marijuana/news/how-are-charlottes-web-products-created  https://www.youtube.com/watch?v=1bVU2bN64Fg

^[913] Colorado Springs-area mom Paige Figi on mission for medical marijuana. http://gazette.com/colorado-springs-area-mom-paige-figi-on-mission-for-medical-marijuana/article/1512458

^[914] Families With Epileptic Children Moving to Colorado For Medical Cannabis Treatment. https://www.alternet.org/drugs/families-epileptic-children-moving-colorado-medical-cannabis-treatment

^[915] CBD Holds Promise as Child Epilepsy Treatment, Studies Find https://www.leafly.com/news/science-tech/cbd-holds-promise-as-child-epilepsy-treatment-studies-find

Which Cannabis Strains Are High in CBD? https://www.leafly.com/news/strains-products/what-cannabis-strains-are-high-in-cbd

What Are High-CBD Cannabis Strains and How Do They Differ From High-THC Strains? https://www.leafly.com/news/cannabis-101/whats-the-deal-with-these-high-cbd-strains

^[916] Sulak, Dustin, Russell Saneto, and Bonni Goldstein. “The current status of artisanal cannabis for the treatment of epilepsy in the United States.” Epilepsy & Behavior 70 (2017): 328-333.

Consroe P, Wolkin A.: Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther. 1977 Apr;201(1):26-32. https://www.ncbi.nlm.nih.gov/pubmed/850145

Medical Marijuana and Epilepsy. https://www.epilepsy.com/learn/treating-seizures-and-epilepsy/other-treatment-approaches/medical-marijuana-and-epilepsy

Ralph Karler, William Cely, Stuart A. Turkanis: The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 1973 Dec 1;13(11):1527-31. https://www.ncbi.nlm.nih.gov/pubmed/4768980

What is CBN (Cannabinol)?https://www.leafscience.com/2017/08/28/what-is-cbn-cannabinol/

^[917] Brenda E. Porter, Catherine Jacobson: Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 2013 Dec; 29(3): 574–577. doi:  10.1016/j.yebeh.2013.08.037

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/

^[918] Sulak, Dustin, Russell Saneto, and Bonni Goldstein. “The current status of artisanal cannabis for the treatment of epilepsy in the United States.” Epilepsy & Behavior 70 (2017): 328-333.

^[919] Devinsky O¹, Cilio MR, Cross H. et al.: Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. https://www.ncbi.nlm.nih.gov/pubmed/24854329

Ralph Karler, William Cely, Stuart A. Turkanis: The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 1973 Dec 1;13(11):1527-31. https://www.ncbi.nlm.nih.gov/pubmed/4768980

^[920] Drysdale, Alison J. et al.: Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. Neuropharmacology 50.5 (2006): 621-631. https://www.ncbi.nlm.nih.gov/pubmed/16386766

Mechoulam, R., E. Shohami: Endocannabinoids and traumatic brain injury. Molecular Neurobiology 36.1 (2007): 68-74. https://www.ncbi.nlm.nih.gov/pubmed/17952651

^[921] Ryan, Duncan et al.: Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. The Journal of Neuroscience 29.7 (2009): 2053-2063. https://pdfs.semanticscholar.org/470f/2d6d2537a3a435859be237513908cdc1bbf2.pdf

^[922] Esposito, Guiseppe et al.: Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement. Published: December 5, 2011https://doi.org/10.1371/journal.pone.0028668

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028668

Campos, Alline C. et al.: The Anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involment of the endocannabinoid system. International Journalof Neuropsychopharmacology 16.6 (2013): 1407-1419. https://www.ncbi.nlm.nih.gov/pubmed/23298518

^[923] Alvarez FJ¹, Lafuente H, Rey-Santano MC. Et al.: Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.

^[924] Sulak, Dustin, Russell Saneto, and Bonni Goldstein. “The current status of artisanal cannabis for the treatment of epilepsy in the United States.” Epilepsy & Behavior 70 (2017): 328-333.

^[925] Russo, Ethan B.: Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug; 163(7): 1344–1364. doi:  10.1111/j.1476-5381.2011.01238.xhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/

^[926] Goldstein, Bonni: Cannabis Revealed. 2016.

^[927] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[928] Cannabis for Pediatric Epilepsy. https://www.marijuana.com/news/2017/02/cannabis-for-pediatric-epilepsy/

^[929] Goldstein, Bonni: Cannabis Revealed. 2016

^[930] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[931] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[932] Nóbrega de Almeida, Reinaldo et al.: Essential olis and their constituents: anticonvulsant activity. Molecules 16.3 (2011): 2726-2742. https://www.mdpi.com/1420-3049/20/11/19649/htm

^[933] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[934] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[935] Goldstein, Bonni: Cannabis Revealed. 2016

^[936] Mechoulam R, Carlini EA. Toward drugs derived from cannabis. Naturwissenschaften. 1978; 65( 4): 174– 179. [PubMed] https://www.ncbi.nlm.nih.gov/pubmed/351429

^[937] Cunha, Jomar M. et al.: Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21.3 (1980):175-185. https://www.ncbi.nlm.nih.gov/pubmed/7413719

^[938] Trembly, B., M. Sherman: Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana´s 90 International Conference on Cannabis and Cannabinoids. Kolympari Crete July 8 Vol. 11 1990. https://www.epistemonikos.org/en/documents/d41032a66cdf9e8d7244283c358128f2576a57a7

^[939] Pelliccia, A.et al.: Treatment with CBD in oily solution of Drug-resistant  Paediatric Epilepsies. Presented at the 2005 Congress on Cannabis and Cannabinoids, Leiden, the Netherlands: IACM. https://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=173&&search_pattern=EPILEPSY

^[940] Porter, Brenda E., Catherine Jacobsson: Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy. Epilepsy & Behavior 29.3 (2013): 574-577. https://www.ncbi.nlm.nih.gov/pubmed/24237632

^[941] Gedde, M., E. Maa: Whole Cannabis Extract of High Concentration Cannabidiol May Calm Seizures in Highly Refractory Pediatric Epilesies. In Press with the American Epilepsy Society 67th Annual Meeting December 2013.

^[942] Blair, RE, Deshpande LS, DeLorenzo, R.J.: Cannabinoids: is there a potential treatment role in  epilepsy? Expert opinion on pharmacotherapy 2015 16 (13): 1911-1914. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845642/

^[943] Hussain, Shaun et al.: Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy & Behavior (2015). https://www.ncbi.nlm.nih.gov/pubmed/25935511

^[944] Marijuana and Epilepsy. http://herb.co/2015/12/28/marijuana-and-epilepsy/

http://herb.co/2016/07/26/everything-you-need-to-know-about-cbd/

^[945] Mechoulam, R., M. Spatz, and E. Shohami. “Endocannabinoids and neuroprotection.” Science Signaling 2002.129 (2002): re5-re5. http://stke.sciencemag.org/content/2002/129/re5

^[946] Snodgrass SR¹.: GABA and epilepsy: their complex relationship and the evolution of our understanding. J Child Neurol. 1992 Jan;7(1):77-86. https://www.ncbi.nlm.nih.gov/pubmed/1313057

^[947] Ethan B Russo: Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug; 163(7): 1344–1364. doi:  10.1111/j.1476-5381.2011.01238.xhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/

^[948] Sulak, Dustin, Russell Saneto, and Bonni Goldstein. “The current status of artisanal cannabis for the treatment of epilepsy in the United States.” Epilepsy & Behavior 70 (2017): 328-333.

^[949] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[950] Cannabis for Pediatric Epilepsy. https://www.marijuana.com/news/2017/02/cannabis-for-pediatric-epilepsy/

^[951] Bonni Goldstein: Cannabis for Pediatric Epilepsy. https://www.marijuana.com/news/2017/02/cannabis-for-pediatric-epilepsy/

^[952] Goldstein, Bonni. Cannabis Revealed 2016.

Iseger TA¹, Bossong MG: A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res. 2015 Mar;162(1-3):153-61. doi: 10.1016/j.schres.2015.01.033. Epub 2015 Feb 7. https://www.ncbi.nlm.nih.gov/pubmed/25667194

^[953] Vezzani, Anna Maria et al.: The role of inflammation in epilepsy. Nature Reviews Neurology 7.1 (2011): 31-40. https://www.ncbi.nlm.nih.gov/pubmed/21135885

Hampson AJ, Grimaldi M, Axelrod J, and Wink D (1998) Cannabidiol and (-)delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268-8273 (CBD reduces glutamate and has antioxidant effects). https://www.ncbi.nlm.nih.gov/pubmed/9653176

Vezzani A. Inflammation and epilepsy. Epilepsy Curr. 2005 Jan-Feb;5(1):1-6. https://www.ncbi.nlm.nih.gov/pubmed/16059445

Lozovaya N, Min R, Tsintsadze V, Burnashev N. Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects. Cell Calcium. 2009 Sep;46(3):154-62. https://www.ncbi.nlm.nih.gov/pubmed/19682741

Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009 Oct;30(10):515-27. https://www.ncbi.nlm.nih.gov/pubmed/19729208

De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S, Stott CG, Di Marzo V. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011 Aug;163(7):1479-94. https://www.ncbi.nlm.nih.gov/pubmed/21175579

Mechoulam R. Plant cannabinoids: a neglected pharmacological treasure trove. Br J Pharmacol. 2005 December; 146(7): 913–915. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751232/

^[954] Russo, Ethan B.: Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug; 163(7): 1344–1364. doi:  10.1111/j.1476-5381.2011.01238.xhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/

^[955] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[956] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[957] Orrin Devinsky, MD, FAAN; Joseph Sullivan; Daniel Friedman et al.:

 Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy.  AAN 67th ANNUAL MEETING ABSTRACT. American Academy of Neurology. https://www.aan.com/PressRoom/Home/GetDigitalAsset/11570

^[957] Bergamaschi MM¹, Queiroz RH, Zuardi AW  al.: Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011 Sep 1;6(4):237-49. https://www.ncbi.nlm.nih.gov/pubmed/22129319

^[958] TREATING PEDIATRIC SEIZURES WITH CANNABINOID MEDICINE https://www.leafly.com/news/health/pediatric-seizure-cannabinoid-marijuana-treatment-risks-benefits

^[959] Sulak, Dustin, Russell Saneto, and Bonni Goldstein. “The current status of artisanal cannabis for the treatment of epilepsy in the United States.” Epilepsy & Behavior 70 (2017): 328-333. https://www.epilepsybehavior.com/article/S1525-5050(16)30477-2/abstract

Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, et al. CBD-

enriched medical cannabis for intractable pediatric epilepsy: the current Israeli

experience. Seizure 2016;35:41–4. https://www.ncbi.nlm.nih.gov/pubmed/26800377

^[960] What Are High-CBD Cannabis Strains and How Do They Differ From High-THC Strains? https://www.leafly.com/news/cannabis-101/whats-the-deal-with-these-high-cbd-strains

^[961] Bonni Goldstein, MD: Cannabis in the Treatment of Pediatric Epilepsy

http://www.theroc.us/researchlibrary/Cannabis%20in%20the%20Treatment%20of%20Pediatric%20Epilepsy.pdf

^[962] TREATING PEDIATRIC SEIZURES WITH CANNABINOID MEDICINE https://www.leafly.com/news/health/how-to-safely-treat-pediatric-seizures-with-cannabinoid-medicine

^[963] How Cannabidiol Helps Children With Epilepsy. https://www.marijuanadoctors.com/resources/ailment-resources/how-cannabidiol-helps-children-with-epilepsy/

^[964]https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf

^[965] USA godkender CBD-præparat til epilepsi. https://www.epilepsiforeningen.dk/nyheder/usa-godkender-cbd-praeparat-epilepsi/

GW Pharmaceuticals Value Doubles After Successful Clinical Trials Results. https://herb.co/marijuana/news/cannabis-drug-successfully-treats-epilepsy-gw-pharmaceuticals-value-doubles

Will The FDA Approve New Cannabis-Extract Epilepsy Drug For Kids? https://herb.co/marijuana/news/fda-cannabis-epilepsy-drug

^[966] Orrin Devinsky, Elizabeth Thiele, Linda Laux et al.: Efficacy and Safety of Epidiolex (Cannabidiol) in Children and Young Adults with Treatment-Resistant Epilepsy: Update from the Expanded Access Program – See more at: https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2414222#sthash.j1Katjdp.dpuf  

The Results from the Largest Medical Marijuana Study Ever Are In. http://www.marijuanatimes.org/the-results-from-the-largest-medical-marijuana-study-ever-are-in/?platform=hootsuite

^[967] Devinsky O¹, Marsh E², Friedman D. et al.: Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24. https://www.ncbi.nlm.nih.gov/pubmed/26724101

^[968] Koo CM¹, Kang HC². Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy? J Epilepsy Res. 2017 Jun 30;7(1):16-20. doi: 10.14581/jer.17003. eCollection 2017 Jun. https://www.ncbi.nlm.nih.gov/pubmed/28775950

^[969] Largest Study Ever On Marijuana And Epilepsy Shows Effectiveness Of Cannabis. http://www.theweedblog.com/largest-study-ever-on-marijuana-and-epilepsy-shows-effectiveness-of-cannabis/

Cannabis Pharmaceutical Epidiolex Aids Children With Epilepsy, Study Finds. https://www.leafly.com/news/science-tech/cannabis-pharmaceutical-epidiolex-helps-children-epilepsy-study-finds

^[970] Marijuana-based anti-seizure drug could hit U.S. market in 2018. https://www.pressherald.com/2018/01/30/marijuana-based-anti-seizure-drug-could-hit-u-s-market-in-2018/

^[971] Study Finds CBD Drug Epidiolex Reduces Seizures by 42%. https://www.leafly.com/news/health/study-finds-cbd-drug-epidiolex-reduces-seizures-by-42

^[972] Elizabeth Athiele, Eric Dmarsh, Jacqueline AFrench et al.: Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, Volume 391, Issue 10125, 17–23 March 2018, Pages 1006-1007. https://www.sciencedirect.com/science/article/pii/S0140673618301363

^[973] Posttraumatisk stresslidelse (PTSD). https://netdoktor.dk/sygdomme/fakta/posttraumatisk_stress.htm

https://www.sundhed.dk/borger/patienthaandbogen/psyke/sygdomme/oevrige-sygdomme/posttraumatisk-stressforstyrrelse/

^[974] Medical Marijuana and Post-Traumatic Stress Disorder (PTSD). https://www.marijuanadoctors.com/conditions/post-traumatic-stress-disorder-ptsd/

Marijuana & PTSD #2: The Science Of Your Brain. http://herb.co/2016/05/03/marijuana-ptsd-2-the-science-of-your-brain/

^[975] J. Douglas Bremner: Traumatic stress: effects on the brain. Dialogues Clin Neurosci. 2006 Dec; 8(4): 445–461. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181836/

^[976] Jonathan E. Sherin, Charles B. Nemeroff: Post-traumatic stress disorder: the neurobiological impact of psychological trauma. Dialogues Clin Neurosci v.13(3); 2011 Sep. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182008/

^[977] Cohen H, Kaplan Z, Matar MA, Loewenthal U, Kozlovsky N, Zohar J. Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress response in rats. Biol Psychiatry. 2006;60(7):767-776. Epub 2006 Jun 2. https://www.ncbi.nlm.nih.gov/pubmed/16735032

Parsons RG, Ressler KJ. Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci.2013;16(2):146-153. Epub 2013 Jan 28. https://www.ncbi.nlm.nih.gov/pubmed/23354388

^[978] Is Marijuana Effective at Combatting Depression? https://herb.co/marijuana/news/is-marijuana-effective-at-combatting-depression/

^[979] Cannabis and Anxiety: What You Need to Know. https://herb.co/marijuana/news/cannabis-and-anxiety-what-you-need-to-know/

^[980] 5 Ways Marijuana Affects Your Sleep. https://herb.co/marijuana/news/5-ways-marijuana-affects-your-sleep/

^[981] Brewin CR. A cognitive neuroscience account of posttraumatic stress disorder and its treatment. Behav Res Ther. 2001;39(4):373-393. https://pdfs.semanticscholar.org/d758/40026b782452422b90dd6908c6b155a516fa.pdf

^[982] http://veteran.forsvaret.dk/Omos/sporgsmal/Pages/default.aspx

^[983] Hvordan og hvor meget rammes veteranerne? https://veteranalliancen.wordpress.com/fakta/krigenes-eftervirkninger-2/

^[984] PTSD: National Center for PTSD. https://www.ptsd.va.gov/public/ptsd-overview/basics/how-common-is-ptsd.asp

^[985] Medical Marijuana and Post-Traumatic Stress Disorder (PTSD). https://www.marijuanadoctors.com/conditions/post-traumatic-stress-disorder-ptsd/

^[986] Ipser JC, Carey P, Dhansay Y, Fakier N, Seedat S, Stein DJ. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005473. https://www.ncbi.nlm.nih.gov/pubmed/17054260

^[986] Albucher RC, Liberzon I. Psychopharmacological treatment in PTSD: a critical review. J Psychiatr Res. 2002;36(6):355-367. https://www.ncbi.nlm.nih.gov/pubmed/12393304

^[987]

Nyt studie: ‘Lykkepiller’ har ingen effekt på depression. https://videnskab.dk/krop-sundhed/nyt-studie-lykkepiller-har-ingen-effekt-paa-depression

^[988] Janus Christian Jakobsen, Kiran Kumar Katakam, Anne Schou et al.: Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC PsychiatryBMC series – open, inclusive and trusted 201717:58

https://doi.org/10.1186/s12888-016-1173-2. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-1173-2

^[989] Posttraumatisk stressforstyrrelse (PTSD). https://www.sundhed.dk/borger/patienthaandbogen/psyke/sygdomme/oevrige-sygdomme/posttraumatisk-stressforstyrrelse/

Medical Marijuana and Post-Traumatic Stress Disorder (PTSD). https://www.marijuanadoctors.com/conditions/post-traumatic-stress-disorder-ptsd/

^[990] Benzodiazepiner. http://radiodoktoren.dk/radiodoktoren/2014/06/16/benzodia

^[991] Gøtzsche, Peter: Dødelig medicin og organiseret kriminalitet. Hvordan medicinalindustrien har korrumperet sundhedsvæsenet. People´s Press 2013.

^[992] Healy D. Pharmageddon. Berkely: Universitet of California Press 2012. Her omtalt i Gøtzsche, Peter: Dødelig medicin og organiseret kriminalitet. Hvordan medicinalindustrien har korrumperet sundhedsvæsenet. People´s Press 2013.

^[993] Antipsykotisk medicin. https://www.sundhed.dk/borger/patienthaandbogen/sundhedsoplysning/medicininformationer/laegemidler/antipsykotisk-medicin/

^[994] PTSD Patient Survey. https://www.projectcbd.org/sites/projectcbd/files/downloads/ptsd-patient-survey_2016_march.pdf

SURVEY: CANNABIS BETTER THAN BIG PHARMA MEDS FOR PTSD https://www.projectcbd.org/about/patient-experiencesurveys/survey-cannabis-better-big-pharma-meds-ptsd

^[995] Anxiety. https://www.projectcbd.org/condition/10/Anxiety

^[996] Depression. https://www.projectcbd.org/condition/18/Depression

^[997] Chronic Pain. https://www.projectcbd.org/condition/37/Neuropathic-Pain

^[998] Sleep Disorders. https://www.projectcbd.org/condition/48/Sleep-Disorders

^[999] Earleywine M, Bolles JR. Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation. J Psychoactive Drugs. 2014;46(3):171-177. https://www.ncbi.nlm.nih.gov/pubmed/25052875

^[1000] Bonn-Miller MO, Vujanovic AA, Drescher KD. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addict Behav. 2011;25(3):485-491. https://www.ncbi.nlm.nih.gov/pubmed/21261407

^[1001] Cameron C, Watson D, Robinson J.: Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. J Clin Psychopharmacol. 2014;34(5):559-564. https://www.ncbi.nlm.nih.gov/pubmed/24987795

^[1002] 5 Surprising Facts About PTSD and Weed. https://herb.co/marijuana/news/5-surprising-facts-about-ptsd-and-weed/

^[1003] Cannabis And Mental Health: Does It Help? https://herb.co/marijuana/news/cannabis-mental-health-help/

^[1004] Marijuana & PTSD: #1 Coping With The Symptoms. https://herb.co/marijuana/news/marijuana-ptsd-coping-with-symptoms/

^[1005] Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. J Trauma Stress. 2007;20:577–86. https://www.ncbi.nlm.nih.gov/pubmed/17721963

Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Amer J Psychiatry. 1996;153:369–75. https://www.ncbi.nlm.nih.gov/pubmed/17721963

Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO. Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders. Int Rev Psychiatry. 2014;26:237–47. https://www.ncbi.nlm.nih.gov/pubmed/24892898

^[1006] 5 Surprising Facts About PTSD and Weed. https://herb.co/marijuana/news/5-surprising-facts-about-ptsd-and-weed/

Viviana Trezza, Patrizia Campolongo: The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD). Front. Behav. Neurosci., 09 August 2013 | https://doi.org/10.3389/fnbeh.2013.00100 https://www.frontiersin.org/articles/10.3389/fnbeh.2013.00100/full

How Cannabinoids Interact with the Body. https://herb.co/marijuana/news/how-cannabinoids-interact-with-the-body/

^[1007] Alger BE. Getting high on the endocannabinoid system. Cerebrum. 2013 Nov 1;2013:14. eCollection 2013.

^[1008] Neumeister A, Normandin MD, Pietrzak RH, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013;18(9):1034-1040. Epub 2013 May 14. https://www.ncbi.nlm.nih.gov/pubmed/23670490

^[1009] Mizrachi Zer-Aviv T¹, Segev A, Akirav I.: Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. Behav Pharmacol. 2016 Oct;27(7):561-9. doi: 10.1097/FBP.0000000000000253. https://www.ncbi.nlm.nih.gov/pubmed/27551883

^[1010] Alexander Neumeister,Marc D. Normandin, Robert H. Pietrzak et al.: Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study. Mol Psychiatry. 2013 September ; 18(9): 1034–1040. doi:10.1038/mp.2013.61. https://secure.hawaiianethos.com/assets/resources/2013%20Neumeister%20-%20Elevated%20Brain%20Cannabinoid%20CB1%20Receptor%20Availability%20in%20Posttraumatic%20Stress%20Disorder.pdf

^[1011] Brain-imaging study links cannabinoid receptors to post-traumatic stress disorder: First pharmaceutical treatment for PTSD within reach. https://www.sciencedaily.com/releases/2013/05/130514085016.htm

A Neumeister, M D Normandin, R H Pietrzak et al.: Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Molecular Psychiatry, 2013; DOI: 10.1038/mp.2013.61

^[1012]  Giovanni Marsicano, Carsten T. Wotjak et al.: The endogenous cannabinoid system controls extinction of aversive memories. Nature volume 418, pages 530–534 (01 August 2002). https://www.semanticscholar.org/paper/The-endogenous-cannabinoid-system-controls-of-Marsicano-Wotjak/8047a8a28d952669afbe9f2b9e8ca958ed0b40ce

^[1013] How CBD Works. https://www.projectcbd.org/science/cannabis-pharmacology/how-cbd-works

Fraser GA: The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009 Winter;15(1):84-8. doi: 10.1111/j.1755-5949.2008.00071.x. https://www.ncbi.nlm.nih.gov/pubmed/19228182

^[1014] Ganon-Elazar E, Akirav I, “Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal, prefrontal circuit,” Psycho-neuroendocrinology, 2013 Feb 20.

Cannabinoid Science Sheds New Light on the Darkness of PTSD https://www.projectcbd.org/article/cannabinoid-science-sheds-new-light-darkness-ptsd

^[1015] Hill, MN, et al., “Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks,” Psychoneuroendocrinology, 2013 Sept 10.

^[1016] How The Medical Cannabis Program Helps My PTSD. https://www.weednews.co/how-the-medical-cannabis-program-helps-my-ptsd/

^[1017] Øget risiko for selvmord ved PTSD. http://www.kompleksptsd.dk/fakta-om-ptsd/oeget-risiko-selvmord-ved-ptsd/

Preventing Suicide among Veterans. https://www.hsrd.research.va.gov/news/feature/suicide_prevention.cfm

Hudenko W., Homaifar B. and Wortzel H. U. S. Department of veterans affairs. “The relationship between PTSD and suicide.” www.ptsd.va.gov. 7. juli 2016.

Cannabis Is Best Treatment For Post-Traumatic Stress Syndrome. https://medicalmarijuana411.com/marijuana-treating-ptsd/

^[1018] DEA Approves First-Ever Trial of Medical Marijuana for PTSD in Veterans. http://www.maps.org/news/media/6141-press-release-dea-approves-first-ever-trial-of-medical-marijuana-for-ptsd-in-veterans

Sisley SA. Issues and controversies around marijuana use: What’s the buzz?. Presented at: American Psychiatric Association Annual Meeting; May 5-9, 20178; New York.

First FDA-approved study of cannabis for PTSD in veterans underway. https://www.healio.com/psychiatry/ptsd/news/online/%7Bac35ff1a-3729-416e-bdfa-f0a6d68d5f43%7D/first-fda-approved-study-of-cannabis-for-ptsd-in-veterans-underway

^[1019] William Hudenko, Beeta Homaifar, Hal Wortzel: The Relationship Between PTSD and Suicide. https://www.ptsd.va.gov/professional/co-occurring/ptsd-suicide.asp

^[1020] D. Mark Anderson, Daniel I. Rees, Joseph J. Sabia: Medical Marijuana Laws and Suicides by Gender and Age. American Journal of Public Health (ajph) December 2014.https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612

^[1021] Mom Overjoyed: “Medical Marijuana Saved My Son’s Life”. https://herb.co/marijuana/news/mom-overjoyed-medical-marijuana-saved-my-sons-life/

^[1022] Guillem E, Arbabzadeh-Bouchez S, Vorspan F, Bellivier F. Comorbidity in 207 cannabis users in a specific outpatient setting[Article in French]. Encephale. 2014 Aug 11. pii: S0013-7006(14)00155-9. [Epub ahead of print]

^[1023] Veterans Use Medical Marijuana to Treat Symptoms of Post-Traumatic Stress Disorder (PTSD). http://www.medicaljane.com/2013/01/05/veterans-and-medical-marijuana/

Synthetic THC May Help in the Treatment of Phobias. http://www.medicaljane.com/2013/08/05/american-study-tetrahydrocannabinol-thc-may-help-phobia-treatment/

^[1024] Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci. 2011 Jun 23;5:34. eCollection 2011.

^[1025] Neumeister A. The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depress Anxiety. 2013;30(2):93-96. Epub 2012 Dec 5.

^[1026] 5 Surprising Facts About PTSD and Weed. https://herb.co/marijuana/news/5-surprising-facts-about-ptsd-and-weed

^[1027] Roitman P¹, Mechoulam R, Cooper-Kazaz R, Shalev A: Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014 Aug;34(8):587-91. doi: 10.1007/s40261-014-0212-3. https://www.ncbi.nlm.nih.gov/pubmed/24935052

^[1028] Brain-imaging study links cannabinoid receptors to post-traumatic stress disorder: First pharmaceutical treatment for PTSD within reach. https://www.sciencedaily.com/releases/2013/05/130514085016.htm

A Neumeister, M D Normandin, R H Pietrzak, D Piomelli et al.: Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Molecular Psychiatry, 2013; DOI: 10.1038/mp.2013.61

^[1029] Ranganathan M¹, D’Souza DC.: The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl). 2006 Nov;188(4):425-44. Epub 2006 Sep 26. https://www.ncbi.nlm.nih.gov/pubmed/17019571

Marijuana and Your Memory. https://herb.co/marijuana/news/marijuana-and-your-memory/

Medical Marijuana and Post-Traumatic Stress Disorder (PTSD). https://www.marijuanadoctors.com/conditions/post-traumatic-stress-disorder-ptsd/

^[1030] Torsten Passie et al.: Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence. Drug Testing and Analysis 4(7-8):649-59 · July 2012. https://www.researchgate.net/publication/228071411_Mitigation_of_post-traumatic_stress_symptoms_by_Cannabis_resin_A_review_of_the_clinical_and_neurobiological_evidence

^[1031] Hash virker mod posttraumatisk stress. https://videnskab.dk/krop-sundhed/hash-virker-mod-posttraumatisk-stress%20

^[1032] Eti Ganon-Elazar, Irit Akirav: Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance. Journal of Neuroscience 9 September 2009, 29 (36) 11078-11088; DOI: https://doi.org/10.1523/JNEUROSCI.1223-09.2009. http://www.jneurosci.org/content/29/36/11078

^[1033] Marijuana May Hold Promise As Treatment For PTSD. http://www.huffingtonpost.com/2014/11/22/cannabis-ptsd_n_6199254.html

Nachshon Korem, Irit Akirav: Cannabinoids Prevent the Effects of a Footshock Followed by

Situational Reminders on Emotional Processing. Neuropsychopharmacology (2014) 39, 2709–2722. http://www.nature.com/articles/npp2014132.pdf 

^[1034] 7 Ways Cannabis Is Great For Your Brain. https://herb.co/marijuana/news/7-ways-cannabis-great-brain/

^[1035] Giovanni Marsicano, Carsten T. Wotjak et al.: The endogenous cannabinoid system controls extinction of aversive memories. Nature volume 418, pages 530–534 (01 August 2002). https://www.semanticscholar.org/paper/The-endogenous-cannabinoid-system-controls-of-Marsicano-Wotjak/8047a8a28d952669afbe9f2b9e8ca958ed0b40cei

^[1036] In PTSD, a good night’s sleep means feeling safe. https://www.sciencenews.org/blog/scicurious/ptsd-good-night’s-sleep-means-feeling-safe

^[1037] 5 Ways Marijuana Affects Your Sleep. https://herb.co/marijuana/news/5-ways-marijuana-affects-your-sleep/

^[1038] Fraser GA¹. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009 Winter;15(1):84-8. doi: 10.1111/j.1755-5949.2008.00071.x. https://www.ncbi.nlm.nih.gov/pubmed/19228182

Pablo Roitman, Raphael Mechoulam, Rena Cooper-Kazaz, Arieh Shalev: Preliminary, Open-Label, Pilot Study of Add-On Oral Δ⁹-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder. Clinical Drug Investigation

August 2014, Volume 34, Issue 8, pp 587-591. http://link.springer.com/article/10.1007%2Fs40261-014-0212-3

^[1039] Fusar-Poli P¹, Crippa JA, Bhattacharyya S. et al.: Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009 Jan;66(1):95-105. doi: 10.1001/archgenpsychiatry.2008.519. https://www.ncbi.nlm.nih.gov/pubmed/19124693

^[1040] Fusar-Poli P¹, Crippa JA, Bhattacharyya S. et al.: Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009 Jan;66(1):95-105. doi: 10.1001/archgenpsychiatry.2008.519. https://www.ncbi.nlm.nih.gov/pubmed/19124693

^[1041] Marcel O. Bonn-Miller, Kimberly A. Babson, Ryan Vandrey: Using Cannabis To Help You Sleep: Heightened Frequency of Medical Cannabis Use among Those with PTSD. Drug Alcohol Depend. 2014 Mar 1; 136: 162–165.

Published online 2013 Dec 31. doi:  10.1016/j.drugalcdep.2013.12.008 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/

^[1042] Why Teens Are Impulsive, Addiction-Prone And Should Protect Their Brains. https://www.npr.org/2016/04/15/474348291/why-teens-are-impulsive-addiction-prone-and-should-protect-their-brains

^[1043] Cameron C, Watson D, Robinson J.: Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. J Clin Psychopharmacol. 2014;34(5):559-564. https://www.ncbi.nlm.nih.gov/pubmed/24987795

Cannabinoids and Posttraumatic Stress Disorder. http://naturalmedicinejournal.com/journal/2014-12/cannabinoids-and-posttraumatic-stress-disorder

^[1044] As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets. https://www.scientificamerican.com/article/as-vets-demand-cannabis-for-ptsd-science-races-to-unlock-its-secrets/?wt.mc=SA_Facebook-Share

^[1045] Record-High Support for Legalizing Marijuana Use in U.S. https://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx

^[1046] McAllister SD¹, Murase R, Christian RT, Lau D. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. https://www.ncbi.nlm.nih.gov/pubmed/20859676

^[1047] Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2014 Dec 10. https://www.ncbi.nlm.nih.gov/pubmed/25503438

National Cancer Institute. Cannabis and Cannabinoids (PDQ^®) Health Professional Version, updated 12/17/14. Accessed at www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional on March 4, 2015

Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2009;72(5):906-911. https://www.ncbi.nlm.nih.gov/pubmed/19344127

Ross SA, ElSohly MA, Sultana GN, et al. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem Anal. 2005;16(1):45-48. https://pdfs.semanticscholar.org/0d43/7073db46bb373bd63562be4797b641b95208.pdf

^[1048] Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167-179. http://files.iowamedicalmarijuana.org/petition/2012/Johnson_2010.pdf

Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage. 2013;46(2):207-218. https://www.ncbi.nlm.nih.gov/pubmed/23141881

Karst M, Salim K, Burstein S, et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003;290:1757-1762. https://www.ncbi.nlm.nih.gov/pubmed/14519710

Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556-1563. https://www.ncbi.nlm.nih.gov/pubmed/24778283

^[1049] One-Quarter of Cancer Patients Use Medical Marijuana, Study Finds. https://www.livescience.com/60500-cancer-patients-medical-marijuana.html

^[1050] Steven A. Pergam, Maresa C. Woodfield, Christine M. Lee et al: Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 25 September 2017. http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/abstract;jsessionid=E39DED42C71A0EE118AFDB093864100A.f03t03

Study finds up to one-quarter of cancer patients use marijuana. https://www.eurekalert.org/pub_releases/2017-09/w-sfu092117.php

^[1051] Marijuana-Like Drugs May Offer Addiction-Free Pain Relief. https://www.livescience.com/56876-marijuana-like-drugs-may-relieve-pain-without-addiction-risk.html

^[1052] Leading Medical Cannabis Advocate United Patients Group Calls for New Research into Cancer-Killing Effects of Cannabis Extracts. http://www.prweb.com/releases/research-cancer/cannabis-extracts/prweb11564012.htm

^[1053] Researchers Demand Extensive Clinical Trials For Cancer, Cannabinoid Treatment. https://www.medicaljane.com/2014/02/11/researchers-demand-extensive-clinical-trials-for-cancer-cannabinoid-treatment/

^[1054] Carsten Vagn-Hansen: Cannabisolie og kræft.  http://www.forebyg.dk/cannabisolie-og-kraeft/

^[1055] Guillermo Velasco, Sonia Hernández-Tiedra, David Dávila, Mar Lorente: The use of cannabinoids as anticancer agents. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4 ;64:259-66. Epub 2015 Jun 10. PMID: 26071989. http://www.greenmedinfo.com/substance/cannabis?ed=1137

^[1056] Cannabis and Cannabinoids (PDQ®)–Health Professional Version. https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

^[1057] Marijuana kills cancer cells, confirms US government. http://metro.co.uk/2015/04/10/marijuana-kills-cancer-cells-confirms-us-government-5144623/

^[1058] Cancer Institute Finally Admits Marijuana Kills Cancer. http://herb.co/2015/10/02/cancer-institute-finally-admits-marijuana-kills-cancer/

^[1059] Cannabis kan i laboratoriet dræbe kræftceller og bremse sklerose. https://videnskab.dk/krop-sundhed/cannabis-kan-draebe-kraeftceller-og-bremse-sklerose

Hash dræber kræftceller og bremser sklerose. https://nordjyske.dk/nyheder/hash-draeber-kraeftceller-og-bremser-sklerose/87827fac-3b65-4b56-b4d0-b7ec79f91d8e

^[1060] María Salazar,1,2 Arkaitz Carracedo,1 Íñigo J. Salanueva et al.: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009;119(5):1359–1372. https://doi.org/10.1172/JCI37948. https://www.jci.org/articles/view/37948

^[1061] Cannabidiol (CBD): Fighting Inflammation & Aggressive Forms of Cancer. https://www.medicaljane.com/2012/12/20/cannabidiol-cbd-medicine-of-the-future/

Cannabigerol (CBG): A Minor Cannabinoid With A Major Impact. https://www.medicaljane.com/2013/08/03/cannabigerol-cbg-is-a-minor-cannabinoid-with-major-impact/

^[1062] Study: Cannabinoids May Combine To Effectively Treat Leukemia. https://www.medicaljane.com/2013/10/14/british-study-cannabinoids-may-combine-to-effectively-treat-cancer/

^[1063] Medical Marijuana May Treat Aggressive Forms Of Breast Cancer. https://www.medicaljane.com/2013/10/17/study-cannabis-may-treat-aggressive-forms-of-breast-cancer/

Studies Show Cannabinoids May Help Fight Triple-Negative Breast Cancer. https://www.medicaljane.com/2015/02/28/studies-suggest-cannabinoids-may-fight-certain-forms-of-breast-cancer/

Cannabis Vs. Cancer: Studies Suggest Cannabinoids May Kill Human Cancer Cells

https://www.medicaljane.com/2013/12/18/studies-suggest-cannabinoids-may-kill-human-cancer-cells/

^[1064] Study: Cannabis Offers Possible Treatment for High Grade Gliomas

https://www.medicaljane.com/2014/11/29/cannabinoids-as-treatment-for-high-grade-gliomas/

Study: Cannabidiol (CBD) May Inhibit Brain Cancer. https://www.medicaljane.com/2013/11/29/study-how-might-cannabidiol-cbd-inhibit-brain-cancer/

GW Pharmaceuticals Begins Trials On Treating Brain Cancer With Sativex

https://www.medicaljane.com/2013/11/13/cannabis-based-brain-cancer-treatment-begins-human-trials/

Study: THC Encourages Neuroplasticity In The Brain. https://www.medicaljane.com/2013/07/23/study-shows-thc-can-help-encourage-neuroplasticity/

^[1065] Meet The Woman Who Says She Beat Her Lung Cancer With Cannabis Oil

https://www.medicaljane.com/2015/06/11/meet-the-woman-who-beat-her-lung-cancer-with-cannabis-oil/

Cannabidiol (CBD) May Increase Lung Cancer’s Susceptibility To Specialized Killer Cells

https://www.medicaljane.com/2014/08/28/study-cannabinoids-may-increase-lung-cancers-susceptibilty-to-specialized-killercells/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis&muuid=bb560bb4XXXd515XXX414eXXX81b2XXXd2f8ae4c445e

^[1066] Study: Anandamide May Fight Aggressive Skin Cancer

https://www.medicaljane.com/2013/09/28/european-study-anandamide-may-fight-aggressive-skin-cancer/

^[1067] Japanese Study Shows Cannabinoids Inhibit Tumor Growth

https://www.medicaljane.com/2013/07/27/study-shows-cannabinoids-inhibit-tumor-growth/

^[1068] Yadvinder Singh, Chamandeep Bali: Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation. Case Rep Oncol. 2013 Sep-Dec; 6(3): 585–592.

Published online 2013 Nov 28. doi:  10.1159/000356446  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/

^[1069] Study shows non-hallucinogenic cannabinoids are effective anti-cancer drugs – St George’s, University of London. https://www.sgul.ac.uk/news/news-archive/study-shows-non-hallucinogenic-cannabinoids-are-effective-anti-cancer-drugs

^[1070] Office of Cancer Complementary and Alternative Medicine (OCCAM). https://cam.cancer.gov/

^[1071] Does Cannabis Cure Cancer? http://herb.co/2017/02/10/cannabis-cure-cancer/

^[1072] Cancer Institute Finally Admits Marijuana Kills Cancer. http://herb.co/2015/10/02/cancer-institute-finally-admits-marijuana-kills-cancer/

http://herb.co/2016/08/25/cannabis-kills-cancer/?bt_alias=eyJ1c2VySWQiOiAiZWY3N2M3MmEtYTJjNS00MzFhLWJhYzUtOWUyNjU0YjMwYjUxIn0%3D

^[1073] Everything You Need To Know About Cannabis And Cancer Treatment

http://herb.co/2017/07/20/cannabis-cancer-treatment/

Preet A, Qamri Z, Nasser MW, et al.: Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila) 4 (1): 65-75, 2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/   

^[1073] Nasser MW, Qamri Z, Deol YS, et al.: Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One 6 (9): e23901, 2011. https://www.ncbi.nlm.nih.gov/pubmed/21915267  

^[1074] Bandana Chakravarti,^#1 Janani Ravi,^#2 and Ramesh K. Ganju: Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014 Aug; 5(15): 5852–5872.

Published online 2014 Jul 17. doi:  10.18632/oncotarget.2233. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171598/

^[1075] Ashutosh Shrivastava, Paula M. Kuzontkoski, Jerome E. Groopman og Anil Prasad. Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy. Molecular Cancer Therapeutics July 2011 Volume 10, Issue 7. http://mct.aacrjournals.org/content/10/7/1161.full

Can Cannabis Fight Breast Cancer? http://herb.co/2016/02/27/can-cannabis-fight-breast-cancer/

^[1076] “Miracle” Cannabis Saved Her From Terminal Stage IV Lung Cancer. http://herb.co/2016/06/21/cannabis-saved-terminal-lung-cancer/

Sánchez C, de Ceballos ML, Gomez del Pulgar T, et al.: Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61 (15): 5784-9, 2001. https://www.ncbi.nlm.nih.gov/pubmed/11479216  

McKallip RJ, Lombard C, Fisher M, et al.: Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100 (2): 627-34, 2002. https://www.ncbi.nlm.nih.gov/pubmed/12091357

Casanova ML, Blázquez C, Martínez-Palacio J, et al.: Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111 (1): 43-50, 2003. https://www.ncbi.nlm.nih.gov/pubmed/12511587  

Blázquez C, González-Feria L, Alvarez L, et al.: Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 64 (16): 5617-23, 2004.  https://www.ncbi.nlm.nih.gov/pubmed/15313899

^[1077] Mahaut Leconte,^*† Carole Nicco,^* Charlotte Ngô et al.: Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis. Am J Pathol. 2010 Dec; 177(6): 2963–2970.

doi:  10.2353/ajpath.2010.100375. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993285/

^[1078] Devon Schuyler: The Link Between Endometriosis and Cancer. Medscape Tuesday, January 3, 2017. http://www.medscape.com/viewarticle/722605

^[1079] T. Fisher, PhD,^*,a H. Golan, MD,^*†,a G. Schiby, MD et al.: In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Curr Oncol. 2016 Mar; 23(Suppl 2): S15–S22.

Published online 2016 Mar 16. doi:  10.3747/co.23.2893. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/

^[1080] National Toxicology Program: NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol (CAS No. 1972-08-3) in F344 rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 446 (): 1-317, 1996.  https://www.ncbi.nlm.nih.gov/pubmed/12594529

Guzmán M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 3 (10): 745-55, 2003.  https://www.cannabis-med.org/data/pdf/en_2006_02_1.pdf

M Guzmán: Effects on cell viability. Handb Exp Pharmacol. 2005(168):627-42. https://www.ncbi.nlm.nih.gov/pubmed/16596790

Blázquez C, Casanova ML, Planas A, et al.: Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17 (3): 529-31, 2003.  https://www.ncbi.nlm.nih.gov/pubmed/12514108

Vaccani A, Massi P, Colombo A, et al.: Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144 (8): 1032-6, 2005.  https://www.ncbi.nlm.nih.gov/pubmed/15700028

Ramer R, Bublitz K, Freimuth N, et al.: Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26 (4): 1535-48, 2012. https://www.ncbi.nlm.nih.gov/pubmed/22198381  

^[1081] Angelo A. Izzo1,4, Francesca Borrelli1,4, Raffaele Capasso et al.: Non-psychotropic plant cannabinoids:

new therapeutic opportunities from an ancient herb. TIPS-730; No of Pages 13. http://cannabisinternational.org/info/Non-Psychoactive-Cannabinoids.pdf

What is CBG (Cannabigerol)? https://www.leafscience.com/2017/04/26/what-is-cbg-cannabigerol/

Velasco G, Sánchez C, Guzmán M: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12 (6): 436-44, 2012. https://www.ncbi.nlm.nih.gov/pubmed/22555283

Cridge BJ, Rosengren RJ: Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag Res 5: 301-13, 2013.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1082] Jun’ichi Nakajima, Dai Nakae, Ken Yasukawa: Structure‐dependent inhibitory effects of synthetic cannabinoids against 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced inflammation and skin tumour promotion in mice. Journal of Pharmacy and Pharmacology Volume65, Issue8 August 2013 Pages 1223-1230. https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.12082

Japanese Study Shows Cannabinoids Inhibit Tumor Growth. http://www.medicaljane.com/2013/07/27/study-shows-cannabinoids-inhibit-tumor-growth/

^[1083] Pot compound seen as tool against cancer. https://www.sfgate.com/health/article/Pot-compound-seen-as-tool-against-cancer-3875562.php#page-1

Can Cannabidiol (CBD) Fight Metastatic Cancer? According to the latest research the answer is yes. http://www.prnewswire.com/news-releases/can-cannabidiol-cbd-fight-metastatic-cancer-according-to-the-latest-research-the-answer-is-yes-170681736.html

^[1084] The Endocannabinoid System and How THC Kills Cancer. https://wakeup-world.com/2014/09/08/the-endocannabinoid-system-and-how-thc-cures-cancer/

^[1085] Cristina Blázquez, Luis González-Feria, Luis Álvarez et al.: Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas. Cancer Research August 2004 Volume 64, Issue 16.http://cancerres.aacrjournals.org/content/64/16/5617

^[1086] Cristina Blázquez, María Salazar, Arkaitz Carracedo et al.: Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression. Cancer Research March 2008 Volume 68, Issue 6. http://cancerres.aacrjournals.org/content/68/6/1945.long

 Cancer Institute Finally Admits Marijuana Kills Cancer. http://herb.co/2015/10/02/cancer-institute-finally-admits-marijuana-kills-cancer/ 

New Research Confirms Cannabis Kills Brain Cancer, NOT Your Brain. http://herb.co/2016/07/01/cannabis-treat-brain-cancer/

THC: Everything You Need To Know About Delta9-Tetrahydrocannabinol. http://herb.co/2016/07/24/what-is-thc/

^[1087] Cannabis & Melanoma: Is There Hope For New Treatment? http://herb.co/2016/03/16/cannabis-melanoma-is-there-hope-for-new-treatment/

Armstrong JL¹, Hill DS², McKee CS² et al.: Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J Invest Dermatol. 2015 Jun;135(6):1629-37. doi: 10.1038/jid.2015.45. Epub 2015 Feb 10. https://www.ncbi.nlm.nih.gov/pubmed/?term=Exploiting+Cannabinoid-Induced+Cytotoxic+Autophagy+to+Drive+Melanoma+Cell+Death

Daniel J. Hermanson and Lawrence J. Marnett: Cannabinoids, Endocannabinoids and Cancer.  Cancer Metastasis Rev. 2011 Dec; 30(3-4): 599–612.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366283/

^[1088] Maurizio Bifulco, Chiara Laezza, Simona Pisanti & Patrizia Gazzerro: Cannabinoids and cancer: pros and cons of an antitumour strategy. British Journal of Pharmacology (2006) 148, 123–135. https://www.theroc.us/researchlibrary/Cannabinoids%20and%20cancer-%20pros%20and%20cons%20of%20an%20antitumour%20strategy.pdf

Massi P¹, Solinas M, Cinquina V, Parolaro D.: Cannabidiol as potential anticancer drug. Br J Clin Pharmacol. 2013 Feb;75(2):303-12. doi: 10.1111/j.1365-2125.2012.04298.x. https://www.ncbi.nlm.nih.gov/pubmed/22506672

Velasco G¹, Sánchez C, Guzmán M.: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247. https://www.ncbi.nlm.nih.gov/pubmed/22555283

^[1089] Cannabis and Cannabinoids (PDQ®)–Patient Version. https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq#link/_5

Guillermo Velasco, Cristina Sánchez1, Manuel Guzmán: Towards the use of cannabinoids as antitumour agents. Nature Reviews Cancer 12, 436–444 (2012). http://www.nature.com/articles/nrc3247

^[1090] M Guzmán, C Sánchez, I Galve-Roperh: Control of the cell survival/death decision by cannabinoids. J Mol Med. 2001;78(11):613-25. https://www.researchgate.net/publication/12062592_Control_of_cell_survivaldeath_decision_by_cannabinoids

V M Pushkarev, O I Kovzun, M D Tronko: Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers? Exp Oncol. 2008 Mar ;30(1):6-21. https://www.ncbi.nlm.nih.gov/pubmed/18438336

^[1091] Sánchez, C · Galve-Roperh, I · Canova, C · Brachet, P · Guzmán, M.: Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998 Sep 25;436(1):6-10. https://www.ncbi.nlm.nih.gov/pubmed/9771884

CBD, THC, and Cancer. https://www.projectcbd.org/about/laboratorypreclinical-studies/cbd-thc-and-cancer

^[1092] Sarfaraz S¹, Adhami VM, Syed DN. Et al.: Cannabinoids for cancer treatment: progress and promise. Cancer Res. 2008 Jan 15;68(2):339-42. doi: 10.1158/0008-5472.CAN-07-2785. https://www.ncbi.nlm.nih.gov/pubmed/18199524

^[1093] Cannabis får kræftceller til at begå selvmord. http://www.ladanesa.com/temaadebat/43-nyheder/temaadebat/4818-cannabis-far-kraeftceller-til-at-bega-selvmord

^[1094] María Salazar,^1,2 Arkaitz Carracedo,¹ Íñigo J. Salanueva et al.: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009 May 1; 119(5): 1359–1372.

Published online 2009 Apr 1. doi:  10.1172/JCI37948 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673842/

^[1095] Daniel J. Hermanson, Lawrence J. Marnett: Cannabinoids, Endocannabinoids and Cancer. Cancer Metastasis Rev. 2011 December ; 30(3-4): 599–612. doi:10.1007/s10555-011-9318-8. https://www.theroc.us/researchlibrary/Cannabinoids,%20Endocannabinoids%20and%20Cancer.pdf

^[1096] Velasco G¹, Sánchez C, Guzmán M.: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247. https://www.ncbi.nlm.nih.gov/pubmed/22555283

^[1097] Guillermo Velasco^, , Sonia Hernández-Tiedra1, David Dávila1, Mar Lorente1: The use of cannabinoids as anticancer agents. Progress in Neuro-Psychopharmacology and Biological Psychiatry

Marta Solinas, Paola Massi, Valentina Cinquina: Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect. PLOS October 21, 2013 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076918

Volume 64, 4 January 2016, Pages 259–266. http://www.sciencedirect.com/science/article/pii/S0278584615001190

^[1098] Federal Cancer Institute Acknowledges Cancer-Fighting Properties of Cannabis. http://reset.me/story/federal-cancer-institute-acknowledges-cancer-fighting-properties-of-cannabis/

^[1099] Paola Massi,¹ Marta Solinas,² Valentina Cinquina et al.: Cannabidiol as potential anticancer drug. Br J Clin Pharmacol. 2013 Feb; 75(2): 303–312. Published online 2012 Apr 17. doi:  10.1111/j.1365-2125.2012.04298.x

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579246/

^[1100] 20 Medical Studies That Show Cannabis Can Be A Potential Cure For Cancer. https://www.collective-evolution.com/2013/08/23/20-medical-studies-that-prove-cannabis-can-cure-cancer/

McAllister SD¹, Murase R, Christian RT. Et al.: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. https://www.ncbi.nlm.nih.gov/pubmed/20859676

^[1101] Luciano De Petrocellis, Dominique Melck, Antonella Palmisano et al: The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. PNAS July 7, 1998 95 (14) 8375-8380; https://doi.org/10.1073/pnas.95.14.8375. http://www.pnas.org/content/95/14/8375

^[1102] Shrivastava A, Kuzontkoski PM, Groopman JE, et al.: Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther 10 (7): 1161-72, 2011. https://www.ncbi.nlm.nih.gov/pubmed/21566064  

Nasser MW, Qamri Z, Deol YS, et al.: Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One 6 (9): e23901, 2011. https://www.ncbi.nlm.nih.gov/pubmed/21915267

 Cannabis and Cannabinoids (PDQ®)–Health Professional Version. http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1103] Caffarel MM, Andradas C, Mira E, et al.: Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer 9: 196, 2010.  https://www.researchgate.net/publication/45281051_Cannabinoids_reduce_ErbB2-driven_breast_cancer_progression_through_Akt_inhibition

McAllister SD, Murase R, Christian RT, et al.: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 129 (1): 37-47, 2011. https://www.ncbi.nlm.nih.gov/pubmed/20859676

^[1104] Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz et al.: Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapeutics May 25, 2006, DOI: https://doi.org/10.1124/jpet.106.105247. http://jpet.aspetjournals.org/content/early/2006/05/25/jpet.106.105247

^[1105] María M Caffarel, Clara Andradas, Emilia Mira et al.: Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Molecular Cancer20109:196. https://doi.org/10.1186/1476-4598-9-196.https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196

^[1106] Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Molecular Cancer Therapeutics November 2007. http://mct.aacrjournals.org/content/6/11/2921.long

^[1107] Medical Marijuana May Treat Aggressive Forms Of Breast Cancer. http://www.medicaljane.com/2013/10/17/study-cannabis-may-treat-aggressive-forms-of-breast-cancer/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis

^[1108] María M Caffarel, Clara Andradas, Emilia Mira et al.: Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Molecular Cancer20109:196 https://doi.org/10.1186/1476-4598-9-196. https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196#B4

^[1109] Rock EM¹, Sticht MA, Duncan M.: Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. Br J Pharmacol. 2013 Oct;170(3):671-8. doi: 10.1111/bph.12322. https://www.ncbi.nlm.nih.gov/pubmed/23902479

Study: Cannabinoids Show Potential In Reducing Nausea. https://www.medicaljane.com/2013/09/03/cannabinoids-show-potential-in-reducing-nausea/

^[1110] Amr A.Fouada Waleed H.Albualib, Abdulruhman S. et al.: Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity. Environmental Toxicology and Pharmacology Volume 36, Issue 2, September 2013, Pages 347-357. http://www.sciencedirect.com/science/article/pii/S1382668913001129

Cannabidiol (CBD) Significantly Reduced Cardiac Damage From Chemotherapy Drug Doxorubicin. https://www.medicaljane.com/2013/08/14/cannabidiol-cbd-significantly-reduced-heart-damage-from-chemotherapy/

^[1111] Studies Show Cannabinoids May Help Fight Triple-Negative Breast Cancer. https://www.medicaljane.com/2015/02/28/studies-suggest-cannabinoids-may-fight-certain-forms-of-breast-cancer/

^[1112] Mohamad Elbaz, Mohd W. Nasser, Janani Ravi et al.: Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer. Molecular Oncology Volume 9, Issue 4 April 2015 Pages 906–919. http://onlinelibrary.wiley.com/doi/10.1016/j.molonc.2014.12.010/full

^[1113] Paula Morales^†, Sandra Blasco-Benito‡^∥, Clara Andradas et al.: Selective, Nontoxic CB₂ Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer. J. Med. Chem., 2015, 58 (5), pp 2256–2264

DOI: 10.1021/acs.jmedchem.5b00078. http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b00078

^[1114] Meet Stefanie LaRue: Cancer Survivor and Medical Marijuana Advocate. https://www.medicaljane.com/2015/02/03/stefanie-larue-cancer-survivor-and-advocate-credits-cannabis/

What is whole plant cannabis oil? https://www.medicaljane.com/question/what-is-whole-plant-weed-oil-made-from-cannabis/

^[1115] Derfor støtter jeg Moffe: Mine kræftknuder er svundet med medicinsk cannabis. https://www.dr.dk/nyheder/regionale/sjaelland/derfor-stoetter-jeg-moffe-mine-kraeftknuder-er-svundet-med-medicinsk

^[1116] Grandmother-of-10 ditches chemotherapy after she claims CANNABIS oil caused her cancerous breast tumour to shrink to an eighth of the size and her case has sparked the interest of scientists. https://www.dailymail.co.uk/health/article-5034701/Gran-s-tumour-shrinks-eighth-size-CANNABIS-oil.html

^[1117] Glioblastoma Multiforme. http://emedicine.medscape.com/article/283252-overview

MarcusSchleyac1SonjaStänderb1JohnKerner et al.: Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Research Bulletin Volume 79, Issue 5, 30 June 2009, Pages 333-337.

Study: Cannabidiol (CBD) May Inhibit Brain Cancer. http://www.medicaljane.com/2013/11/29/study-how-might-cannabidiol-cbd-inhibit-brain cancer/?utm_sour.%3Futm_source=mantis&utm_medium=recommend&utm_campaign=mantis

^[1118] Journal of Neuroscience Research November 2008 High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.

http://onlinelibrary.wiley.com/doi/10.1002/jnr.21757/abstract

123 Studies Show Cannabis Can Help Cure Cancer. http://www.exposingtruth.com/123-cannabis-cancer/

Guzmán M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 3 (10): 745-55, 2003. [PUBMED Abstract] http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1119] Sánchez, C · Galve-Roperh, I · Canova, C · Brachet, P · Guzmán, M.: Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998 Sep 25;436(1):6-10. https://www.ncbi.nlm.nih.gov/pubmed/9771884

CBD, THC, and Cancer. https://www.projectcbd.org/about/laboratorypreclinical-studies/cbd-thc-and-cancer

^[1120] Guzman et al. 2000. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Medicine 6: 313-319.

^[1121] Guzman et al. 2003. Inhibition of tumor angiogenesis by cannabinoids. The FASEB Journal 17: 529-531. https://www.ncbi.nlm.nih.gov/pubmed/12514108

^[1122] Allister et al. 2005. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. Journal of Neurooncology 74: 31-40. https://www.ncbi.nlm.nih.gov/pubmed/16078104

^[1123] Foroughi et al. 2011. Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas — possible role of cannabis inhalation. Child’s Nervous System 27: 671-679. https://www.researchgate.net/publication/49851195_Spontaneous_regression_of_septum_pellucidumforniceal_pilocytic_astrocytomas_-_Possible_role_of_Cannabis_inhalation

^[1124] Cafferal et al. 2006. Delta-9-Tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Research 66: 6615-6621.

Di Marzo et al. 2006. Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapeutics Fast Forward 318: 1375-1387. https://www.ncbi.nlm.nih.gov/pubmed/16728591

De Petrocellis et al. 1998. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 95: 8375-8380. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20983/

McAllister et al. 2007. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Molecular Cancer Therapeutics 6: 2921-2927.

Cafferal et al. 2010. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Molecular Cancer 9: 196.

^[1125] Sarfaraz et al. 2005. Cannabinoid receptors as a novel target for the treatment of prostate cancer. Cancer Research 65: 1635-1641.

Mimeault et al. 2003. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines. Prostate 56: 1-12.

Ruiz et al. 1999. Delta-9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Letters 458: 400-404.

Ramos and Bianco. 2012. The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. Journal of Urology 28: 9-14.

DePetrocellis et al. 2013. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. British Journal of Pharmacology 168: 79-102.

^[1126] Pastos et al. 2005. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase-2. Gut 54: 1741-1750.

Aviello et al. 2012. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. Journal of Molecular Medicine [E-pub ahead of print]

^[1127] Di Marzo et al. 2006. Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapeutics Fast Forward 318: 1375-1387

^[1128] Casanova et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. 2003. Journal of Clinical Investigation 111: 43-50

^[1129] Powles et al. 2005. Cannabis-induced cytotoxicity in leukemic cell lines. Blood 105: 1214-1221

Jia et al 2006. Delta-9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemic T cells in regulated by translocation of Bad to mitochondria. Molecular Cancer Research 4: 549-562.

Liu et al. 2008. Enhancing the in vitro cytotoxic activity of Ä9-tetrahydrocannabinol in leukemic cells through a combinatorial approach. Leukemia and Lymphoma 49: 1800-1809.

Scott et al. 2013. Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules 33: 4373-4380.

Kampa-Schittenhelm et al. 2016. Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns. BMC Cancer. Open access at: http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8.

^[1130] Manuel Guzman. 2003. Cannabinoids: potential anticancer agents (PDF). Nature Reviews Cancer 3: 745-755.

Marcu et al. 2010. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Molecular Cancer Therapeutics 9: 180-189.

^[1131] Guzman et al. 2003. Inhibition of tumor angiogenesis by cannabinoids. The FASEB Journal 17: 529-531

Preet et al. 2008. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 10: 339-346.

^[1132] Manuel Guzman. 2003. Cannabinoids: potential anticancer agents (PDF). Nature Reviews Cancer 3: 745-755.

^[1133] Baek et al. 1998. Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells. Archives of Pharmacal Research: 21: 353-356.

^[1134] Carracedo et al. 2006. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Research 66: 6748-6755.

Michalski et al. 2008. Cannabinoids in pancreatic cancer: correlation with survival and pain. International Journal of Cancer 122: 742-750.

^[1135] Ramer and Hinz. 2008. Inhibition of cancer cell invasion by cannabinoids via increased cell expression of tissue inhibitor of matrix metalloproteinases-1. Journal of the National Cancer Institute 100: 59-69.

Sindiswa and Motadi. 2016. Cannabidiol rather than cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells. BMC Complimentary and Alternative Medicine 16: 336.

^[1136] Whyte et al. 2010. Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology 85: 328-335.

^[1137] Leelawat et al. 2010. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Cancer Investigation 28: 357-363.

^[1138] Gustafsson et al. 2006. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. Molecular Pharmacology70: 1612-1620.

Gustafsson et al. 2008. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation. International Journal of Cancer 123: 1025-1033.

^[1139] Torres et al. 2011. A combined preclinical therapy of cannabinoids and Temozolomide against glioma. Molecular Cannabis Therapeutics 10: 90.

Scott et al. 2013. Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules 33: 4373-4380.

^[1140] M Guzmán,^1,* M J Duarte,² C Blázquez et al.: A pilot clinical study of Δ⁹-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006 Jul 17; 95(2): 197–203.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/

Hernán Pérez de la Ossa D¹, Ligresti A, Gil-Alegre ME. Et al.: Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy. J Control Release. 2012 Aug 10;161(3):927-32. doi: 10.1016/j.jconrel.2012.05.003. Epub 2012 May 10. https://www.ncbi.nlm.nih.gov/pubmed/22580111

^[1141] Paola Massi, Angelo Vaccani, Stefania Ceruti et al.: Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines. Journal of Pharmacology and Experimental Therapeutics March 2004, 308 (3) 838-845; DOI: https://doi.org/10.1124/jpet.103.061002. http://jpet.aspetjournals.org/content/308/3/838

^[1142] United Kingdom Studies CBD in Treating Children’s Brain Tumors. https://medicalmarijuana411.com/united-kingdom-studies-cbd-treating-childrens-brain-tumors/

^[1143] New research to test effect of cannabidiol on child brain tumours. https://www.nottingham.ac.uk/news/pressreleases/2017/may/new-research-to-test-effect-of-cannabidiol-on-child-brain-tumours.aspx

^[1144] Guillermo Velasco: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. https://www.medicalnewstoday.com/releases/144770.php  

Cannabis reduces tumor growth in study. https://www.medicalnewstoday.com/articles/279571.php

^[1145] United Kingdom Studies CBD in Treating Children’s Brain Tumors. https://medicalmarijuana411.com/united-kingdom-studies-cbd-treating-childrens-brain-tumors/

^[1146] Medical Marijuana and Leukemia. https://www.marijuanadoctors.com/conditions/leukemia/

^[1147] Leukæmi – blodkræft. https://www.cancer.dk/leukaemi-blodkraeft/

^[1148] Treatment Response Rates for Acute Myeloid Leukemia. https://www.cancer.org/cancer/acute-myeloid-leukemia/treating/response-rates.html

^[1149] Cancer treatments may harm the heart. https://www.health.harvard.edu/heart-health/cancer-treatments-may-harm-the-heart

^[1150] Lung damage and chemotherapy. http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/chemotherapy-and-other-drug-therapies/chemotherapy/side-effects-of-chemotherapy/lung-damage-and-chemotherapy/?region=on

^[1151] Chemotherapy side effects: A cause of heart disease? https://herb.co/marijuana/news/cannabis-effective-leukemia

^[1152] E.A. Livesey’, P.C. Hindmarsh’, C.G.D. Brook et al.: Endocrine disorders following treatment of childhood brain tumours. Br. J. Cancer (1990), 61, 622-625. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971355/pdf/brjcancer00224-0132.pdf

^[1153] How Cancer Treatments Can Affect Fertility in Women. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/fertility-and-sexual-side-effects/fertility-and-women-with-cancer/how-cancer-treatments-affect-fertility.html

^[1154] Bone Health. https://www.nccn.org/patients/resources/life_with_cancer/treatment/bone_health.aspx

^[1155] Colin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé et al.: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature Genetics volume 41, pages 1345–1349 (2009)

doi:10.1038/ng.478. http://www.nature.com/articles/ng.478

^[1156] Peripheral Neuropathy Caused by Chemotherapy. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/peripheral-neuropathy.html

^[1157] Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici et al.: Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study. Biology of Blood and Marrow Transplantation October 2015Volume 21, Issue 10, Pages 1770–1775. http://www.bbmt.org/article/S1083-8791%2815%2900375-4/fulltext

^[1158] Kerstin Maria Kampa-Schittenhelm, Olaf Salitzky, Figen Akmut et al.: Dronabinol has preferential antileukemic

activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns. BMC Cancer (2016) 16:25. https://www.theroc.us/researchlibrary/Dronabinol%20has%20preferential%20antileukemic%20activity%20in%20acute%20lymphoblastic%20and%20myeloid%20leukemia%20with%20lymphoid%20differentiation%20patterns.pdf  

^[1159] Wentao Jia, Venkatesh L. Hegde, Narendra P. Singh et al.: #9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat

Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria. Mol Cancer Res 2006;4(8). August 2006. https://www.theroc.us/researchlibrary/D9-Tetrahydrocannabinol-Induced%20Apoptosis%20in%20Jurkat%20Leukemia%20T%20Cells%20Is%20Regulated%20by%20Translocation%20of%20Bad%20to%20Mitochondria.pdf

^[1160] Thomas Powles, Robert te Poele, Jonathan Shamash et al.: Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood 2005 105:1214-1221; doi: https://doi.org/10.1182/blood-2004-03-1182 http://www.bloodjournal.org/content/105/3/1214.long?sso-checked=true

^[1161] 20 Medical Studies That Show Cannabis Can Be A Potential Cure For Cancer. https://www.collective-evolution.com/2013/08/23/20-medical-studies-that-prove-cannabis-can-cure-cancer/

Kristin Gustafsson, Birger Christensson, Birgitta Sander et al.: Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma. Molecular Pharmacology November 2006, 70 (5) 1612-1620; DOI: https://doi.org/10.1124/mol.106.02598. http://molpharm.aspetjournals.org/content/70/5/1612

^[1162] Jia W¹, Hegde VL, Singh NP. Et al.: Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug;4(8):549-62. https://www.ncbi.nlm.nih.gov/pubmed/16908594

^[1163] Kristin Gustafsson, Xiao Wang, Denise Severa et al.: Expression of cannabinoid receptors type 1 and type 2 in non‐Hodgkin lymphoma: Growth inhibition by receptor activation. International Journal of Cancer Volume123, Issue5

1 September 2008. Pages 1025-1033. https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.23584

^[1164] GuillermoVelasco, SoniaHernández-Tiedra, DavidDávila et al.: The use of cannabinoids as anticancer agents. Progress in Neuro-Psychopharmacology and Biological Psychiatry Volume 64, 4 January 2016, Pages 259-266. https://www.sciencedirect.com/science/article/pii/S0278584615001190

^[1165] Daniel J. Hermanson, Lawrence J. Marnett: Cannabinoids, Endocannabinoids and Cancer. Published in final edited form as: Cancer Metastasis Rev. 2011 Dec; 30(3-4): 599–612.  doi:  10.1007/s10555-011-9318-8.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366283/

^[1166] Katherine A. Scott, Angus G. Dalgleish, Wai M. Liu: Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration. International Journal of Oncology juli 2017 Volume 51 Issue 1. https://www.spandidos-publications.com/ijo/51/1/369

^[1167] Pediatric Supportive Care (PDQ®)–Patient Version. https://www.cancer.gov/types/childhood-cancers/pediatric-care-pdq

^[1168] Does Cannabis Cure Cancer? https://herb.co/marijuana/news/cannabis-cure-cancer

Is Cannabis Oil The Solution To Treating Cancer In Children? https://herb.co/marijuana/news/is-cannabis-oil-the-solution-to-treating-cancer-in-children

^[1169] Robert J. McKallip, Catherine Lombard, Michael Fisher et al.: Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002 100:627-634; doi: https://doi.org/10.1182/blood-2002-01-0098. http://www.bloodjournal.org/content/100/2/627.long?sso-checked=true

^[1170] Jia W¹, Hegde VL, Singh NP. Et al.: Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug;4(8):549-62. https://www.ncbi.nlm.nih.gov/pubmed/16908594

^[1171] Jenny Flygare, Kristin Gustafsson, Eva Kimby et al.: Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. FEBS Letters Volume579, Issue30 December 19, 2005 Pages 6885-6889.https://febs.onlinelibrary.wiley.com/doi/full/10.1016/j.febslet.2005.11.020

^[1172] Kristin Gustafsson, Xiao Wang, Denise Severa et al.: Expression of cannabinoid receptors type 1 and type 2 in non‐Hodgkin lymphoma: Growth inhibition by receptor activation. International Journal of Cancer Volume123, Issue5

1 September 2008. Pages 1025-1033. https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.23584

^[1173] MosheYeshurun¹²OferShpilberg¹²CorinaHerscovici et al.: Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study. Biology of Blood and Marrow Transplantation Volume 21, Issue 10, October 2015, Pages 1770-1775. https://www.sciencedirect.com/science/article/pii/S1083879115003754

^[1174] DRUGS: CHEMOTHERAPY DRUGS AND OTHER PHARMACEUTICALS. http://www.acco.org/drugs-chemotherapy-drugs-and-other-pharmaceuticals/

Mother Of Colorado 3-Year-Old Sparks Medical Marijuana Debate. https://www.medicaljane.com/2013/10/13/mother-of-colorado-3-year-old-sparks-medical-marijuana-debate/

^[1175] Watch: Cannabis Oil Cures Boy Given 48 Hours To Live. https://herb.co/marijuana/news/watch-cannabis-oil-cures-boy-given-48-hours-to-live

^[1176] Landon Riddle’s Story: 3 Year old beats Leukemia with cannabis oil https://www.youtube.com/watch?v=zbNVe57vKEk

^[1177] Is Cannabis Oil The Solution To Treating Cancer In Children? https://herb.co/marijuana/news/is-cannabis-oil-the-solution-to-treating-cancer-in-children

^[1178] When Is It OK To Give Children Cannabis? http://www.huffingtonpost.co.uk/mary-biles1/child-cannabis-epilepsy_b_13125246.html

^[1179] Singh and Bali. 2013. Cannabis extract treatment for terminal acute lymphoblastic leukemia. Case Reports in Oncology 6: 585-592.

^[1180] The Most Impressive Cannabis Case Study Ever? Treating Terminal Leukemia. http://medicalmarijuana.co.uk/the-most-impressive-cannabis-case-study-ever-curing-girl-14-of-terminal-leukemia/

^[1181] Yadvinder Singh, Chamandeep Bali: Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation. Case Rep Oncol. 2013 Sep-Dec; 6(3): 585–592.

Published online 2013 Nov 28. doi:  [10.1159/000356446]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/

^[1182] The Most Impressive Cannabis Case Study Ever? Treating Terminal Leukemia. https://medicalmarijuana.co.uk/the-most-impressive-cannabis-case-study-ever-curing-girl-14-of-terminal-leukemia/

^[1183] Behandling af lungekræft. https://www.cancer.dk/lungekraeft-lungecancer/behandling-lunge/

^[1184] Ramer R¹, Bublitz K, Freimuth N. et al.: Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23. https://www.ncbi.nlm.nih.gov/pubmed/22198381?dopt=Abstract

Bifulco M, Laezza C, Pisanti S, et al.: Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 148 (2): 123-35, 2006. [PUBMED Abstract] http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1185] Preet A, Ganju RK, Groopman JE: Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 27 (3): 339-46, 2008. [PUBMED Abstract] http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1186] It Is Claimed Marijuana Smoke Contains Carcinogens But Doesn’t Cause Cancer. How? https://herb.co/marijuana/news/marijuana-smoke-contains-carcinogens-doesnt-cause-cancer

Robert Melamede: Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J. 2005; 2: 21.

Published online 2005 Oct 18. doi:  [10.1186/1477-7517-2-21] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277837/

^[1187] Mark J. Pletcher, Eric Vittinghoff, Ravi Kalhan: Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. JAMA. 2012;307(2):173-181. doi:10.1001/jama.2011.1961. https://jamanetwork.com/journals/jama/fullarticle/1104848

^[1188] Tashkin DP.: Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013 Jun;10(3):239-47. doi: 10.1513/AnnalsATS.201212-127FR. https://www.ncbi.nlm.nih.gov/pubmed/23802821

^[1189] What marijuana really does to your body and brain. http://www.businessinsider.com/marijuana-weed-mental-physical-effects-2017-1/?r=US&IR=T&IR=T#marijuana-use-affects-the-lungs-but-doesnt-seem-to-increase-the-risk-of-lung-cancer-18

^[1190] Pot Smoking Not Linked to Lung Cancer, https://www.webmd.com/lung-cancer/news/20060523/pot-smoking-not-linked-to-lung-cancer#1

^[1191] American Thoracic Society 102nd International Conference, San Diego, May 23, 2006. Donald Tashkin, MD, professor of medicine, David Geffen School of Medicine, University of California at Los Angeles. Robert Melamede, PhD, molecular biologist, University of Colorado at Colorado Springs. WebMD Medical News: “Pot Smoke: Less Carcinogenic Than Tobacco?”

^[1192] Healthy Lungs #4: The Effects Of Long-Term Marijuana Smoking. http://herb.co/2016/05/11/healthy-lungs-4-effects-of-long-term-marijuana-smoking/

Mia Hashibe, Hal Morgenstern, Yan Cui et al.: Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study. Cancer Epimediology, Biomarkers  & Prevention October 2006 Volume 15, Issue 10. http://cebp.aacrjournals.org/content/15/10/1829.long

^[1193] Li Rita Zhang, Hal Morgenstern, Sander Greenland et al.: Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. International Journal of Cancer Volume136, Issue4

15 February, 2015. https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.29036

^[1194] Anju Preet, Ramesh Ganju and Jerome Groopman. Δ-9 Tetrahydrocannabinol inhibits growth and metastasis of lung cancer. Cancer Research: Experimental and Molecular Therapeutics, May 2007, Volume 67, Issue 9 Supplement [link]

American Association for Cancer Research. “Marijuana cuts lung cancer tumor growth in half, study shows.” ScienceDaily, 17 April 2007. www.sciencedaily.com/releases/2007/04/070417193338.htm

^[1195] 10 Reasons Marijuana Is The Ultimate Preventative Medicine. https://herb.co/marijuana/news/10-reasons-why-marijuana-is-the-ultimate-preventative-medicine

^[1196] Study: Smoking Marijuana Not Linked with Lung Damage. http://healthland.time.com/2012/01/10/study-smoking-marijuana-not-linked-with-lung-damage/

^[1197] Cancer Institute Finally Admits Marijuana Kills Cancer. https://herb.co/marijuana/news/cancer-institute-finally-admits-marijuana-kills-cancer

^[1198] Study: Smoking Marijuana Not Linked with Lung Damage. http://healthland.time.com/2012/01/10/study-smoking-marijuana-not-linked-with-lung-damage/

^[1199] Mark J. Pletcher,  Eric Vittinghoff, Ravi Kalhan et al:: Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. JAMA. 2012;307(2):173-181. doi:10.1001/jama.2011.1961. https://jamanetwork.com/journals/jama/fullarticle/1104848

^[1200] Kempker JA¹, Honig EG, Martin GS.: The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015 Feb;12(2):135-41. doi: 10.1513/AnnalsATS.201407-333OC. https://www.ncbi.nlm.nih.gov/pubmed/25521349

Healthy Lungs #4: The Effects Of Long-Term Marijuana Smoking. http://herb.co/2016/05/11/healthy-lungs-4-effects-of-long-term-marijuana-smoking/

^[1201] Kempker JA¹, Honig EG, Martin GS.: The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015 Feb;12(2):135-41. doi: 10.1513/AnnalsATS.201407-333OC. https://www.ncbi.nlm.nih.gov/pubmed/25521349

^[1202] Donald P Tashkin: Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013 Jun;10(3):239-47. http://www.pubpdf.com/pub/23802821/Effects-of-marijuana-smoking-on-the-lung

^[1203] Manuel Guzmán: CANNABINOIDS: POTENTIAL ANTICANCER AGENTS. NATURE REVIEWS | CANCER VOLUME 3 | OCTOBER 2003 | 745. http://jeffreydachmd.com/wpcontent/uploads/2014/06/guzman_2003_cannabis_as_anticancer_agents.pdf 

Medical Marijuana and Severe Nausea. https://www.marijuanadoctors.com/conditions/severe-nausea/

Does Cannabis Help Chemotherapy-Induced Nausea & Vomiting? https://herb.co/marijuana/news/cannabis-chemotherapy-induced-nausea

^[1204] What Are The Medical Benefits of CBD?https://www.leafscience.com/2017/12/06/medical-benefits-cbd/

How Does Cannabis Help Treat Nausea? https://herb.co/marijuana/news/cannabis-treat-nausea

^[1205] Cannabis and Cannabinoids (PDQ®)–Health Professional Version. https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

Proven Medical Benefits of THC. https://zenpype.com/proven-medical-benefits-of-thc/

^[1206] Ahmedzai S, Carlyle DL, Calder IT, et al.: Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer 48 (5): 657-63, 1983. https://www.ncbi.nlm.nih.gov/pubmed/6315040  

Chan HS, Correia JA, MacLeod SM: Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics 79 (6): 946-52, 1987. https://www.ncbi.nlm.nih.gov/pubmed/3035479

Sutton IR, Daeninck P: Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain. J Support Oncol 4 (10): 531-5, 2006 Nov-Dec. https://www.ncbi.nlm.nih.gov/pubmed/17136871

^[1207] Todaro B¹.: Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw. 2012 Apr;10(4):487-92. https://www.ncbi.nlm.nih.gov/pubmed/22491047

Cannabis, cannabinoids and cancer – the evidence so far http://scienceblog.cancerresearchuk.org/2012/07/25/cannabis-cannabinoids-and-cancer-the-evidence-so-far/

Dronabinol. https://medlineplus.gov/druginfo/meds/a607054.html

Types of anti sickness drugs. http://www.cancerresearchuk.org/about-cancer/coping/physically/sickness/treatment/types-anti-sickness-drugs

Marinol VS THC: What’s The Difference? https://herb.co/marijuana/news/marinol-vs-thc-whats-difference

Dronabinol (By mouth). https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010045/

^[1208] Katherine A Belendiuk, Lisa L Baldini, Marcel O Bonn-Miller: Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice December 2015. https://link.springer.com/article/10.1186/s13722-015-0032-7

^[1209] Medical Marijuana and Severe Nausea. https://www.marijuanadoctors.com/conditions/severe-nausea/

^[1210] 7 Side Effects of Cancer Treatment, and How to Cope with Them. https://www.livescience.com/35522-side-effects-cancer-treatments-coping-tips-110302.html

^[1211] Orr LE, McKernan JF, Bloome B. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch Intern Med. 1980;140:1431–3. https://www.ncbi.nlm.nih.gov/pubmed/6254456

Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006;105:1–25. https://www.ncbi.nlm.nih.gov/pubmed/16540272

Machado Rocha FC, Stefano SC, De Cassia HR, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008;17:431–43. https://www.ncbi.nlm.nih.gov/pubmed/18625004

Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323:16–21. https://www.ncbi.nlm.nih.gov/pubmed/11440936

^[1212] Frytak S, Moertel CG, O’Fallon JR, Rubin J, Creagan ET, O’Connell MJ, et al. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med. 1979;91:825–30. https://www.ncbi.nlm.nih.gov/pubmed/517882

Ungerleider JT, Andrysiak T, Fairbanks L, Goodnight J, Sarna G, Jamison K. Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. Cancer. 1982;50:636–45.https://www.ncbi.nlm.nih.gov/pubmed/6284334

Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin. 2007;23:533–43. https://www.ncbi.nlm.nih.gov/pubmed/17355735

^[1213] Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J, et al. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. J Pain Symptom Manage. 1991;6:352–9. https://www.ncbi.nlm.nih.gov/pubmed/1652611

^[1214] Linda A Parker, Erin M Rock, Cheryl L Limebeer: Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol. 2011 Aug; 163(7): 1411–1422. doi:  10.1111/j.1476-5381.2010.01176.x.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/

^[1215] Parker, Linda A.^CA; Mechoulam, Raphael¹; Schlievert, Coralynne: Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

NeuroReport: April 16th, 2002 – Volume 13 – Issue 5 – p 567–570. http://journals.lww.com/neuroreport/Citation/2002/04160/Cannabidiol,_a_non_psychoactive_component_of.6.aspx

^[1216] Cotter J.: Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review. Oncology Nursing Forum [01 May 2009, 36(3):345-352. http://europepmc.org/abstract/med/19596652

^[1217] Cannabis and Cannabinoids (PDQ®)–Patient Version. https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq#link/_5

Brisbois TD, de Kock IH, Watanabe SM, et al.: Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22 (9): 2086-93, 2011. https://www.ncbi.nlm.nih.gov/pubmed/21343383

^[1218] Cannabis and Cannabinoids (PDQ®)–Patient Version. https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq#section/all

^[1219] Chang AE, Shiling DJ, Stillman RC, et al.: A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer 47 (7): 1746-51, 1981. https://www.ncbi.nlm.nih.gov/pubmed/6261926 

Musty RE, Rossi R: Effects of smoked cannabis and oral delta-9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials. Journal of Cannabis Therapeutics 1 (1): 29-56, 2001. Last accessed December 8, 2016. http://www.cannabis-med.org/iacm/data/pdf/2001-01-2.pdf

^[1220] Chang AE, Shiling DJ, Stillman RC, et al.: Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Ann Intern Med 91 (6): 819-24, 1979. https://www.ncbi.nlm.nih.gov/pubmed/293141

^[1221] Levitt M, Faiman C, Hawks R, et al.: Randomized double blind comparison of delta-9-tetrahydrocannabinol and marijuana as chemotherapy antiemetics. [Abstract] Proceedings of the American Society of Clinical Oncology 3: A-C354, 91, 1984.

^[1222] Sallan SE, Zinberg NE, Frei 3rd E. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med. 1975;293:795–7. https://www.ncbi.nlm.nih.gov/pubmed/1099449

^[1223] Tramèr MR, Carroll D, Campbell FA, et al.: Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323 (7303): 16-21, 2001. https://www.ncbi.nlm.nih.gov/pubmed/11440936

^[1224] Ben Amar M: Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (1-2): 1-25, 2006. https://www.ncbi.nlm.nih.gov/pubmed/16540272  

^[1225]de Jong, Bouke C., Prentiss, Diane et al.: Marijuana Use and Its Association With Adherence to Antiretroviral Therapy Among HIV-Infected Persons With Moderate to Severe Nausea. JAIDS Journal of Acquired Immune Deficiency Syndromes: January 1st, 2005 – Volume 38 – Issue 1 – p 43-46 http://journals.lww.com/jaids/Abstract/2005/01010/Marijuana_Use_and_Its_Association_%20With_Adherence.8.aspx

^[1226] Melissa E Badowski, Sarah E Perez: Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS. HIV AIDS (Auckl). 2016; 8: 37–45. Published online 2016 Feb 10. doi:  10.2147/HIV.S81420. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755463/

^[1227] Machado Rocha FC, Stefano SC, De Cassia HR, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008;17:431–43. https://www.ncbi.nlm.nih.gov/pubmed/18625004

^[1228] Duran M, Pérez E, Abanades S, et al.: Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol 70 (5): 656-63, 2010. https://www.ncbi.nlm.nih.gov/pubmed/21039759

^[1229] Katherine A Belendiuk, Lisa L Baldini, Marcel O Bonn-Miller: Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice December 2015, 10:10. https://link.springer.com/article/10.1186/s13722-015-0032-7

^[1230] Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2014 Dec 10. https://www.ncbi.nlm.nih.gov/pubmed/25503438

National Cancer Institute. Cannabis and Cannabinoids (PDQ^®) Health Professional Version, updated 12/17/14. Accessed at www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional  on March 4, 2015.

Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2009;72(5):906-911. https://www.ncbi.nlm.nih.gov/pubmed/19344127

Ross SA, ElSohly MA, Sultana GN, et al. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem Anal. 2005;16(1):45-48. https://www.ncbi.nlm.nih.gov/pubmed/15688956

^[1231] Lesley A Smith, Fredric Azariah,Verna TC Lavender et al.: Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD009464. DOI: 10.1002/14651858.CD009464.pub2. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/epdf

http://videnskab.dk/krop-sundhed/forskere-effekten-af-cannabis-som-medicin-er-ukendt?utm_source=vores+nyhedsbrev&utm_campaign=82bab5b796-EMAIL_CAMPAIGN_2016_11_22&utm_medium=email&utm_term=0_d2f5c83eb4-82bab5b796-207962645

^[1232] Davis MP¹.: Cannabinoids for Symptom Management and Cancer Therapy: The Evidence. J Natl Compr Canc Netw. 2016 Jul;14(7):915-22. https://www.ncbi.nlm.nih.gov/pubmed/27407130

^[1233] Aya Abrahamov , Avraham Abrahamov and R. Mechoulam: An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102. https://www.ncbi.nlm.nih.gov/pubmed/7776837

^[1234] S. E. Straus & D. L. Sackett: Review on evidence-based cancer medicine. Applying evidence to the individual patient. Annals of Oncology 10: 29-32,1999.

^[1235] Patienter skal nødes med omtanke. https://dsr.dk/sygeplejersken/arkiv/ff-nr-2016-1/patienter-skal-noedes-med-omtanke

^[1236] Mohsen Nematy,¹ Jacqui E O’Flynn,² Liesl Wandrag et al.: Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care. 2006; 10(1): R10.  Published online 2005 Dec 23. doi:  10.1186/cc3957

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550795/

CAROL BRAUNSCHWEIG, SANDRA GOMEZ, PATRICIA MSHEEAN: Impact of Declines in Nutritional Status on Outcomes in Adult Patients Hospitalized for More Than 7 days. Journal of the American Dietetic Association

Volume 100, Issue 11, November 2000, Pages 1316-1322. http://www.sciencedirect.com/science/article/pii/S0002822300003734

^[1237] Depression Sufferers Find Relief in Medical Marijuana. https://www.hellomd.com/health-wellness/depression-sufferers-find-relief-in-medical-marijuana

Ceri Battle, Karen James, P Temblett: Depression following critical illness: Analysis of incidence and risk factors. Journal of the Intensive Care Society. December 2014. https://www.researchgate.net/publication/269705162_Depression_following_critical_illness_Analysis_of_incidence_and_risk_factors

^[1238] The Odd Science Behind Marijuana And Metabolism. http://herb.co/2016/02/01/odd-science-behind-marijuana-metabolism/

How To Control Your Munchies. http://herb.co/2015/08/20/how-to-control-your-munchies/

^[1239] 12 Best Foods to Satisfy the Munchies. http://herb.co/2014/09/10/12-best-foods-to-satisfy-the-munchies/

^[1240] Klok MD¹, Jakobsdottir S, Drent ML: The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007 Jan;8(1):21-34. https://www.ncbi.nlm.nih.gov/pubmed/17212793

^[1241] The Truth About Marijuana And Motivation. http://herb.co/2016/01/24/truth-marijuana-motivation/

^[1242] M.A. De Luca,^1,2,§ M. Solinas,^3,§ Z. Bimpisidis et al.: CANNABINOID FACILITATION OF BEHAVIORAL AND BIOCHEMICAL HEDONIC TASTE RESPONSES.  Neuropharmacology. 2012 Jul; 63(1): 161–168.

Published online 2011 Nov 2. doi:  10.1016/j.neuropharm.2011.10.018 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705914/

^[1243] Cannabinoids and the Immune System. https://www.hellomd.com/health-wellness/cannabinoids-and-the-immune-system

^[1244] The Endocannabinoid System: Cannabis & Your Appetite. https://www.medicaljane.com/2013/07/24/the-endocannabinoid-system-cannabis-appetite/

Study: Cannabis Increases Sensitivity To Smell, Stimulates Appetite. https://www.medicaljane.com/2014/02/14/study-suggests-cannabis-increases-sensitivity-to-smell-stimulates-appetite/

^[1245] Kirkham TC¹. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol. 2005 Sep;16(5-6):297-313. https://www.ncbi.nlm.nih.gov/pubmed/16148436

^[1246] Elliot MBerry^a..RaphaelMechoulam^b. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacology & Therapeutics Volume 95, Issue 2, August 2002, Pages 185-190. http://www.sciencedirect.com/science/article/pii/S0163725802002577

Pagotto, U., Vicennati, V., & Pasquali, R. (2005). The endocannabinoid system and the treatment of obesity. Annals of Medicine. 37(4):270-5. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16019725.

The Endocannabinoid System: Cannabis & Your Appetite. https://www.medicaljane.com/2013/07/24/the-endocannabinoid-system-cannabis-appetite/

Farrimond JA¹, Whalley BJ, Williams CM: Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology (Berl). 2012 Sep;223(1):117-29. doi: 10.1007/s00213-012-2697-x. Epub 2012 Apr 28. https://www.ncbi.nlm.nih.gov/pubmed/22543671

^[1247] 5 Amazing Reasons Weed Makes Food Insanely Good. https://herb.co/marijuana/news/weed-food

Strasser F, Luftner D, Possinger K, et al.: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24 (21): 3394-400, 2006. https://www.ncbi.nlm.nih.gov/pubmed/16849753

Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in Clinical Neuroscience, 9(4), 413–430. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202504.

Medical Marijuana and Wasting Syndrome. https://www.marijuanadoctors.com/conditions/wasting-syndrome/

Avraham Y¹, Ben-Shushan D, Breuer A. et al.: Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav. 2004 Apr;77(4):675-84. https://www.ncbi.nlm.nih.gov/pubmed/15099912

The Endocannabinoid System: Cannabis & Your Appetite. https://www.medicaljane.com/2013/07/24/the-endocannabinoid-system-cannabis-appetite/

Study: Cannabis Increases Sensitivity To Smell, Stimulates Appetite. https://www.medicaljane.com/2014/02/14/study-suggests-cannabis-increases-sensitivity-to-smell-stimulates-appetite/

^[1248] Riggs PK¹, Vaida F, Rossi SS et al.: A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Res. 2012 Jan 11;1431:46-52. doi: 10.1016/j.brainres.2011.11.001. Epub 2011 Nov 7. https://www.ncbi.nlm.nih.gov/pubmed/22133305

Ben Amar M: Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (1-2): 1-25, 2006. http://www.antoniocasella.eu/archila/BenAmar_2006.pdf

^[1249] Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003;139:258–66. https://www.ncbi.nlm.nih.gov/pubmed/12965981

Alin Andries MD^1,*, Jan Frystyk^2,3, Allan Flyvbjerg^, René Klinkby Støving: Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial. International Journal of Eating Disorders

Volume 47, Issue 1, pages 18–23, January 2014. http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/abstract

http://www.leafscience.com/2014/07/22/7-proven-medical-benefits-thc/

^[1250] Haney M. Effects of smoked marijuana in healthy and HIV+ marijuana smokers. J Clin Pharmacol. 2002;42:34S–40. https://www.ncbi.nlm.nih.gov/pubmed/12412834

^[1251] Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, et al. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. 1997;14:7–14. https://www.ncbi.nlm.nih.gov/pubmed/9223837

Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, et al. Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. J Acquir Immune Defic Syndr. 2007;45:545–54. https://www.ncbi.nlm.nih.gov/pubmed/17589370

Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, et al. Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacol (Berl). 2010;212:675–86. https://www.ncbi.nlm.nih.gov/pubmed/20824270

Cannabis and Cannabinoids (PDQ®)–Health Professional Version. https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study. J Clin Oncol. 2002;20:567–73. https://www.ncbi.nlm.nih.gov/pubmed/11786587

Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10:89–97. https://www.ncbi.nlm.nih.gov/pubmed/7730690

^[1252] Foltin RW¹, Fischman MW, Byrne MF.: Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite. 1988 Aug;11(1):1-14. https://www.ncbi.nlm.nih.gov/pubmed/3228283

^[1253] Cannabis Enhances Appetite in Cancer Patients. https://www.medscape.com/viewarticle/738014

^[1254] Edgar Soria-Gómez,Luigi Bellocchio,Leire Reguero et al.: The endocannabinoid system controls food intake via olfactory processes. Nature Neuroscience17, 407–415  (2014) doi:10.1038/nn.3647 Received 26 July 2013  Accepted 09 January 2014  Published online 09 February 2014  http://www.nature.com/neuro/journal/v17/n3/full/nn.3647.html#author-information

^[1255] A Scientific Explanation of How Marijuana Causes the Munchies. https://www.smithsonianmag.com/science-nature/scientific-explanation-how-marijuana-causes-munchies-180949660/#d4yof0ZpxMPPhGCi.99

^[1256] Farrimond JA¹, Whalley BJ, Williams CM: Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology (Berl). 2012 Sep;223(1):117-29. doi: 10.1007/s00213-012-2697-x. Epub 2012 Apr 28. https://www.ncbi.nlm.nih.gov/pubmed/22543671

Celia JA Morgan, Tom P Freeman, Gráinne L Schaferog H Valerie Curran: Cannabidiol Attenuates the Appetitive Effects of Δ₉-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis. Neuropsychopharmacology (2010) 35, 1879–1885; doi:10.1038/npp.2010.58; published online 28 April 2010. http://www.nature.com/npp/journal/v35/n9/abs/npp201058a.html

^[1257] Strasser F, Luftner D, Possinger K, et al.: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24 (21): 3394-400, 2006. https://www.ncbi.nlm.nih.gov/pubmed/16849753  

^[1258] Jatoi A, Windschitl HE, Loprinzi CL, et al.: Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20 (2): 567-73, 2002. https://www.ncbi.nlm.nih.gov/pubmed/11786587

Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2014 Dec 10. https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21260

National Cancer Institute. Cannabis and Cannabinoids (PDQ^®) Health Professional Version, updated 12/17/14. Accessed at www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional  on March 4, 2015.

Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2009;72(5):906-911. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886613/

Ross SA, ElSohly MA, Sultana GN, et al. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem Anal. 2005;16(1):45-48. https://pdfs.semanticscholar.org/0d43/7073db46bb373bd63562be4797b641b95208.pdf

^[1259] Brisbois TD, de Kock IH, Watanabe SM, et al.: Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22 (9): 2086-93, 2011.  https://academic.oup.com/annonc/article/22/9/2086/211788

^[1260] Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (2): 89-97, 1995. https://www.ncbi.nlm.nih.gov/pubmed/7730690

^[1261] Marco Koch,Luis Varela,Jae Geun Kim et al.: Hypothalamic POMC neurons promote cannabinoid-induced feeding. Nature 519, 45–50 (05 March 2015) doi:10.1038/nature14260.

Received 22 March 2014  Accepted 23 January 2015  Published online 18 February 2015 Corrected online 04 March 2015 http://www.nature.com/nature/journal/v519/n7541/full/nature14260.html

Derfor gør cannabis dig sulten. https://videnskab.dk/krop-sundhed/derfor-gor-cannabis-dig-sulten

^[1262] Bar-Sela G^1,2, Tauber D², Mitnik et al.: Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. Anticancer Drugs. 2019 Jan;30(1):91-97. doi: 10.1097/CAD.0000000000000685. https://www.ncbi.nlm.nih.gov/pubmed/30540595

^[1263] Caffarel MM¹, Andradas C, Pérez-Gómez E. et al.: Cannabinoids: a new hope for breast cancer therapy? Cancer Treat Rev. 2012 Nov;38(7):911-8. doi: 10.1016/j.ctrv.2012.06.005. Epub 2012 Jul 7. https://www.ncbi.nlm.nih.gov/pubmed/22776349

^[1264] Nabissi M, Morelli MB, Santoni M, et al.: Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34 (1): 48-57, 2013.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

Maximilian Peters, Natalya M Kogan: A cannabinoid quinone has cancer-destroying activity superior to doxorubicin without cardiotoxicity, in vitro. Expert Opin Investig Drugs. 2007 Sep;16(9):1405-13.

^[1265] Cannabis and Cannabinoids (PDQ®)–Health Professional Version. https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

María Salazar,^1,2 Arkaitz Carracedo,¹ Íñigo J. Salanueva et al.: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009 May 1; 119(5): 1359–1372.

Published online 2009 Apr 1. doi:  10.1172/JCI37948 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673842/

^[1266] Engels FK, de Jong FA, Sparreboom A, et al.: Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. Oncologist 12 (3): 291-300, 2007. https://www.ncbi.nlm.nih.gov/pubmed/17405893

http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1267] Torres et al. 2011. A combined preclinical therapy of cannabinoids and Temozolomide against glioma. Molecular Cannabis Therapeutics 10: 90. https://www.ncbi.nlm.nih.gov/pubmed/21220494

Velasco G, Sánchez C, Guzmán M: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12 (6): 436-44, 2012.  https://www.ncbi.nlm.nih.gov/pubmed/22555283

^[1268] Cannabis compound ‘halts cancer. http://news.bbc.co.uk/2/hi/health/7098340.stm

^[1269] McAllister SD¹, Murase R, Christian RT. Et al.: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. https://www.ncbi.nlm.nih.gov/pubmed/20859676

^[1270] Katherine A. Scott, Angus G. Dalgleish, Wai M. Liu et al.: Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration. International Journal of Oncology. juli 2017 Volume 51 Issue 1. https://www.spandidos-publications.com/ijo/51/1/369 

^[1271] GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma. https://www.gwpharm.com/about/news/gw-pharmaceuticals-achieves-positive-results-phase-2-proof-concept-study-glioma

^[1272] Katherine A. Scott, Angus G. Dalgleish and Wai M. Liu: The Combination of Cannabidiol and Δ⁹-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. Molecular Cancer Therapeutics Published OnlineFirst November 14, 2014 doi: 10.1158/1535-7163.MCT-14-0402

http://mct.aacrjournals.org/content/early/2014/11/12/1535-7163.MCT-14-0402

Ny forskning: Cannabis-ekstrakt fjerner hjernesvulster. http://www.dr.dk/Nyheder/Viden/Naturvidenskab/2014/11/18215138.htm

^[1273] Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Research Bulletin June 2009. http://www.sciencedirect.com/science/article/pii/S0361923009000598

^[1274] Engels FK¹, de Jong FA, Mathijssen RH. Et al.: Medicinal cannabis in oncology. Eur J Cancer. 2007 Dec;43(18):2638-44. Epub 2007 Oct 31. https://www.ncbi.nlm.nih.gov/pubmed/17976975

Ultimate Guide To Strains You Need To Use For Pain Relief. https://herb.co/marijuana/news/cannabis-pain-relief

^[1275] Medical cannabis in the United States. https://en.wikipedia.org/wiki/Medical_cannabis_in_the_United_States

^[1276] Johnson JR, Burnell-Nugent M, Lossignol D, et al.: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 39 (2): 167-79, 2010.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1277] Johnson JR, Lossignol D, Burnell-Nugent M, et al.: An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46 (2): 207-18, 2013. https://www.jpsmjournal.com/article/S0885-3924(12)00439-3/fulltext  

^[1278] Hill KP.: Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015 Jun 23-30;313(24):2474-83. doi: 10.1001/jama.2015.6199. https://www.ncbi.nlm.nih.gov/pubmed/26103031

^[1279] Ethan B Russo: Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008 Feb; 4(1): 245–259. Published online 2008 Feb. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/

What is CBG (Cannabigerol)? https://www.leafscience.com/2017/04/26/what-is-cbg-cannabigerol/

Marijuana Mouth Spray: Will Cancer Pain Reliever Be Abused? https://www.livescience.com/18212-marijuana-sativex-mouth-spray-abuse.html

Healing Herb? Marijuana Could Treat These 5 Conditions. https://www.livescience.com/55750-medical-marijuana-conditions-treat.html

^[1280] Noyes R Jr, Brunk SF, Baram DA, et al.: Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol 15 (2-3): 139-43, 1975 Feb-Mar. https://www.ncbi.nlm.nih.gov/pubmed/1091664  

^[1281] Noyes R Jr, Brunk SF, Avery DA, et al.: The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18 (1): 84-9, 1975. https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt197518184  

^[1282] Maida V, Ennis M, Irani S, et al.: Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6 (3): 119-24, 2008. https://pdfs.semanticscholar.org/b24d/1922b7ef3d0a9d40eca0a02962237816ea04.pdf

^[1283] Portenoy RK, Ganae-Motan ED, Allende S, et al.: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13 (5): 438-49, 2012.  Abstract]http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1284] Horsted, Tina: Medicinsk Cannabis. Livskvalitet og smertelindring med cannabis medicin. Gyldendal 2018

^[1285] Liam Davenport: Neuropathy After Breast Cancer Chemo Can Last for Years. Medscape Saturday, April 28, 2018. https://www.medscape.com/viewarticle/885106

Donna R. Rivera, Patricia A. Ganz, Meghan S. Weyrich et al.: Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review. JNCI: Journal of the National Cancer Institute, Volume 110, Issue 2, 1 February 2018. https://academic.oup.com/jnci/article-abstract/110/2/djx140/4093778

Palmar Hyperhydrosis and Medical Marijuana. https://www.medicalmarijuana.com/medical-marijuana-treatments-cannabis-uses/palmar-hyperhydrosis-and-medical-mrijuana/

Top Medical Marijuana Strains. https://www.marijuanadoctors.com/blog/top-medical-marijuana-strains/

^[1286] 5 Major Benefits Of Cannabis As Alternative Medicine. https://medicalmarijuana411.com/5-benefits-of-cannabis-as-a-medicine-2/

^[1287] Peripheral Neuropathy. https://www.marijuanadoctors.com/conditions/peripheral-neuropathy/

Judith Feinberg, MD reviewing Abrams DI et al. Neurology 2007 Feb 13.: Marijuana for Painful Peripheral Neuropathy? NEJM Journal Watch April 30, 2007. https://www.jwatch.org/ac200704300000001/2007/04/30/marijuana-painful-peripheral-neuropathy

^[1288] Judith Feinberg, MD reviewing Abrams DI et al. Neurology 2007 Feb 13.: Marijuana for Painful Peripheral Neuropathy? NEJM Journal Watch April 30, 2007. https://www.jwatch.org/ac200704300000001/2007/04/30/marijuana-painful-peripheral-neuropathy

^[1289] Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14:136–48.

^[1290] Cannabis giver nyt håb til syge. http://www.bt.dk/danmark/cannabis-giver-nyt-haab-til-syge

Læge Peter Ege taler om Cannabis. https://www.youtube.com/watch?v=y6efowTggpk

^[1291] Lægemidler med cannabis har ingen eller minimal effekt på største patientgruppe. https://www.information.dk/indland/2018/08/laegemidler-cannabis-ingen-minimal-effekt-paa-stoerste-patientgruppe?lst_rel

^[1292] Overblik: Forsøg med medicinsk cannabis i Danmark. https://videnskab.dk/krop-sundhed/overblik-forsoeg-med-medicinsk-cannabis-i-danmark

^[1293] Det eneste, jeg åbenbart kan få lov til af det danske sundhedssystem, er at lægge mig ned og dø. https://www.information.dk/indland/2016/04/eneste-aabenbart-kan-faa-lov-danske-sundhedssystem-laegge-doe

^[1294] Dansk FN-klage kan skabe global præcedens: Medicinsk cannabis er en menneskerettighed. https://borsen.dk/nyheder/generelt/artikel/1/353232/dansk_fn-klage_kan_skabe_global_praecedens_medicinsk_cannabis_er_en_menneskerettighed.html?utm_source=forside&utm_campaign=nyhed_15

^[1295] Cannabispillerne har fjernet den sorte sky i mine tanker. https://www.information.dk/indland/2016/02/cannabispillerne-fjernet-sorte-sky-tanker

^[1296] Byrådsmedlem: Cannabis har hjulpet mig. http://sn.dk/Ringsted/Byraadsmedlem-Cannabis-har-hjulpet-mig/artikel/693754

^[1297] CANNABIS OLIE MOD SMERTER. https://www.alt.dk/sundhed/ida-havde-smerter-i-27-ar-cannabisolie-har-givet-mig-mit-liv-100-procent-igen

^[1298] Kroniske smerter: Cannabis gav mig et nyt liv. https://www.gigtforeningen.dk/nyheder/2016/2-halvaar/cannabis-gav-mig-et-nyt-liv/

^[1299] Uhelbredeligt syge Louise: Jeg dulmer mine smerter med cannabis

https://ekstrabladet.dk/nyheder/samfund/uhelbredeligt-syge-louise-jeg-dulmer-mine-smerter-med-cannabis/6342296

^[1300] Mange patienter har lige så stor gavn af cannabis som af traditionel medicin. http://www.information.dk/549023

^[1301] Horsted, Tina: Medicinsk Cannabis. Livskvalitet og smertelindring med cannabis medicin. Gyldendal 2018

^[1302] Tina Horsted: To ud af tre olier er for dyre for patienterne. https://propatienter.dk/nyheder/1605-tina-horsted-to-ud-af-tre-olier-er-for-dyre-for-patienterne.html

^[1303] Charles W. Webb, Sandra M. Webb: Therapeutic Benefits of Cannabis: A Patient Survey. Hawaii Journal of Medicine and Public Health 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/

60 Peer-Reviewed Studies on Medical Marijuana. https://medicalmarijuana.procon.org/view.resource.php?resourceID=000884

^[1304] Laird Harrison: Inhaled Cannabis Promising for Painful Diabetic Neuropathy. Medscape Saturday, April 28, 2018. https://www.medscape.com/viewarticle/848539

Mark S. Wallace, Thomas D. Marcotte, Anya Umlauf et al.: Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. Journal of Pain July 2015Volume 16, Issue 7, Pages 616–627. https://www.jpain.org/article/S1526-5900(15)00601-X/abstract

Bonn-Miller MO¹, Boden MT, Bucossi MM.: Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8. https://www.ncbi.nlm.nih.gov/pubmed/24205805

Greenwell GT¹.: Medical marijuana use for chronic pain: risks and benefits. J Pain Palliat Care Pharmacother. 2012;26(1):68-9. doi: 10.3109/15360288.2011.652350. https://www.ncbi.nlm.nih.gov/pubmed/22448949

^[1305] Igor Grant,^*,1 J. Hampton Atkinson,^1,2 Ben Gouaux et al.: Medical Marijuana: Clearing Away the Smoke. Open Neurol J. 2012; 6: 18–25. Published online 2012 May 4. doi:  10.2174/1874205X01206010018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/

^[1306] Kevin P. Hill, MD, MHS: Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric ProblemsA Clinical Review. JAMA. 2015;313(24):2474-2483. doi:10.1001/jama.2015.6199. https://jamanetwork.com/journals/jama/article-abstract/2338266

^[1307] Abrams DI, Jay CA, Shade SB, et al.: Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68 (7): 515-21, 2007. https://www.ncbi.nlm.nih.gov/pubmed/17296917

^[1308] Medical Marijuana: Benefits, Risks & State Laws.https://www.livescience.com/24554-medical-marijuana.html

^[1309] Kathleen Doheny: Marijuana Relieves Chronic Pain, Research Shows. http://www.webmd.com/pain-management/news/20100830/marijuana-relieves-chronic-pain-research-show

^[1310] Mark A. Ware, Tongtong Wang, Stan Shapiro et al.: Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ October 5, 2010 vol. 182 no. 14 First published August 30, 2010, doi: 10.1503/cmaj.091414. http://www.cmaj.ca/content/182/14/E694.abstract

^[1311] BarthWilsey, ThomasMarcotte, ReenaDeutsch et al.: Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain. The Journal of Pain Volume 14, Issue 2, February 2013, Pages 136-148. https://www.sciencedirect.com/science/article/pii/S1526590012008644

^[1312] Katherine A Belendiuk, Lisa L Baldini, Marcel O Bonn-Miller: Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice. December 2015, 10:10.  https://link.springer.com/article/10.1186/s13722-015-0032-7

Wilsey B¹, Marcotte T, Deutsch R. et al.: Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009. Epub 2012 Dec 11. https://www.ncbi.nlm.nih.gov/pubmed/23237736

Bonn-Miller MO¹, Boden MT, Bucossi MM.: Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8. https://www.ncbi.nlm.nih.gov/pubmed/24205805

Greenwell GT¹.: Medical marijuana use for chronic pain: risks and benefits. J Pain Palliat Care Pharmacother. 2012;26(1):68-9. doi: 10.3109/15360288.2011.652350. https://www.ncbi.nlm.nih.gov/pubmed/22448949

^[1313] Martín-Sánchez E, Furukawa TA, Taylor J, Martin JL. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med. 2009;10:1353–68. https://www.ncbi.nlm.nih.gov/pubmed/19732371

^[1314] Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One. 2010;5:e14433. https://www.ncbi.nlm.nih.gov/pubmed/21203440

^[1315] Howard Meng, Bradley Johnston, Marina Englesakis et al.: Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis. Anesth Analg. 2017 May 19. Epub 2017 May 19. PMID: 28537982.https://app.dimensions.ai/details/publication/pub.1085554122

^[1316] Ellis RJ, Toperoff W, Vaida F, et al.: Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34 (3): 672-80, 2009. https://www.ncbi.nlm.nih.gov/pubmed/18688212

Cannabis Company Designs Pain Patch For Fibromyalgia And Nerve Pain. https://herb.co/marijuana/news/cannabis-pain-patch

^[1317] Lynch ME, Cesar-Rittenberg P, Hohmann AG: A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J Pain Symptom Manage 47 (1): 166-73, 2014.  https://www.ncbi.nlm.nih.gov/pubmed/23742737

Ultimate Guide To Strains You Need To Use For Pain Relief. http://herb.co/2016/08/03/cannabis-pain-relief/

Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438-449. http://files.iowamedicalmarijuana.org/petition/2012/Portenoy_2012.pdf

^[1318] Wilsey B, Marcotte T, Tsodikov A, et al.: A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 9 (6): 506-21, 2008. https://www.ncbi.nlm.nih.gov/pubmed/18403272

^[1319] Wilsey B, Marcotte T, Deutsch R, et al.: Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 14 (2): 136-48, 2013. https://www.ncbi.nlm.nih.gov/pubmed/23237736  

Medical Marijuana and Neuropathy. https://www.marijuanadoctors.com/conditions/neuropathy/

^[1320] Libat Weizman, Lior Dayan, Silviu Brill et al.: Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. Neurology. 2018 Sep 5. Epub 2018 Sep 5. http://n.neurology.org/content/early/2018/09/05/WNL.0000000000006293

^[1321] Physicians Recommend Cannabis As An Effective Treatment of Chronic Pain. https://www.medicaljane.com/2014/06/13/chronic-pain-and-the-theraputic-benefits-of-medical-cannabis/

Whole-Plant Cannabis as Add-On Therapy for Chronic Non-Cancer Pain. https://www.medicaljane.com/2014/12/31/study-study-whole-plant-cannabis-as-add-on-therapy-for-chronic-non-cancer-pain/

Physician’s Organization in Canada Releases Guidelines for Prescribing Medical Cannabis for Pain. https://www.medicaljane.com/2014/12/31/physicians-organization-in-canada-releases-guidelines-for-prescribing-medical-cannabis-for-pain/

^[1322] Systematic Review: Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain.https://www.medicaljane.com/2015/02/13/cannabinoids-in-the-treatment-of-chronic-nonmalignant-neuropathic-pain/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis&muuid=bb560bb4XXXd515XXX414eXXX81b2XXXd2f8ae4c445e

Vaporizing Cannabis: Possible Treatment For Neuropathic Pain Symptoms. https://www.medicaljane.com/2013/08/16/vaporizing-cannabis-is-an-effective-treatment-for-neuropathic-pain/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis&muuid=bb560bb4XXXd515XXX414eXXX81b2XXXd2f8ae4c445e

^[1323] Prakash Nagarkatti,^† Rupal Pandey,^* Sadiye Amcaoglu Rieder et al.: Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. Author manuscript; available in PMC 2010 Aug 1.

Published in final edited form as: Future Med Chem. 2009 Oct; 1(7): 1333–1349.  doi:  10.4155/fmc.09.93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/

^[1324] Oleson EB¹, Cheer JF: A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a012229. doi: 10.1101/cshperspect.a012229.https://www.ncbi.nlm.nih.gov/pubmed/22908200

^[1325] DeLong GT¹, Wolf CE, Poklis A, Lichtman AH: Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. Drug Alcohol Depend. 2010 Nov 1;112(1-2):126-33. doi: 10.1016/j.drugalcdep.2010.05.019. https://www.ncbi.nlm.nih.gov/pubmed/20619971

^[1326] J Manzanares,^1,* MD Julian,¹ and A Carrascosa: Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes. Curr Neuropharmacol. 2006 Jul; 4(3): 239–257. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430692/

^[1327] Peter M. Zygmunt, David A. Andersson and Edward D. Högestätt: Δ⁹-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB₁ and CB₂ Cannabinoid Receptor-Independent Mechanism. Journal of Neuroscience 1 June 2002, 22 (11) 4720-4727. http://www.jneurosci.org/content/22/11/4720.full

^[1328] Wilsey B¹, Marcotte T, Deutsch R et al.: Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009. Epub 2012 Dec 11. https://www.ncbi.nlm.nih.gov/pubmed/23237736

^[1329] Peripheral Neuropathy. https://www.marijuanadoctors.com/conditions/peripheral-neuropathy/

^[1330] Walker JM, Hohmann AG, Martin WJ, et al.: The neurobiology of cannabinoid analgesia. Life Sci 65 (6-7): 665-73, 1999.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

Meng ID, Manning BH, Martin WJ, et al.: An analgesia circuit activated by cannabinoids. Nature 395 (6700): 381-3, 1998.  https://www.ncbi.nlm.nih.gov/pubmed/9759727

Walker JM, Huang SM, Strangman NM, et al.: Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 96 (21): 12198-203, 1999.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1331] Facci L, Dal Toso R, Romanello S, et al.: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A 92 (8): 3376-80, 1995. https://www.ncbi.nlm.nih.gov/pubmed/7724569

 Ibrahim MM, Porreca F, Lai J, et al.: CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 102 (8): 3093-8, 2005. https://www.ncbi.nlm.nih.gov/pubmed/15705714  

Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75 (1): 111-9, 1998.  http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all

^[1332] Ways to Consume Medical Marijuana. https://www.marijuanadoctors.com/resources/methods-medicating-cannabis/